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CLOSTRIDIUM DIFFICILE INFECTION OCCURRENCE IN ACADEMIC HEALTH 
CENTERS:  DO ORGANIZATIONAL FACTORS MATTER? 
By Amy Pakyz, PharmD, MS 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University 
Virginia Commonwealth University, 2014 
Director:  Yasar A. Ozcan, Ph.D. 
 
 Healthcare-associated infections occur commonly in hospitals and have a major 
impact on patient well-being.  The occurrence of the healthcare-associated infection, 
Clostridium difficile, has been occurring more frequently among hospitalized patients 
due to an epidemic strain, and is an important cause of antibiotic-associated diarrhea 
and colitis.  This study examined the impact of several organizational factors on the 
occurrence of C. difficile infection (CDI) in hospitals using an institutional theory 
perspective.   
 Administrative claims were utilized from University HealthSystem Consortium 
hospitals to obtain hospital-level data for the calendar year 2011.  Data were available 
for 89 hospitals.   Hospital-level analyses, negative binomial regression models, were 
conducted to test eight developed hypotheses and the associations between 
organizational factors and the incidence of CDI in hospitals.  Cases of CDI were risk-
adjusted for known factors associated with CDI.  
  
 After controlling for factors known to be associated with CDI, the results of the 
analyses showed that one study hypothesis was supported.  That is, hospitals with 
higher Leapfrog Group Safety Scores had CDI rates that were no different than 
hospitals with lower Safety Scores.  Further, it was found that U.S. News and World 
Report Best Hospital Honor Roll member hospitals had significantly higher occurrence 
of CDI as compared to non-Honor Roll member hospitals, though it was predicted that 
there would be no difference in CDI rates.  The organizational factors state-led CDI 
prevention collaboratives, state mandatory CDI reporting, Magnet status, the rate of 
central line-associated bloodstream infections and catheter-associated urinary tract 
infections, and CDI physician champions, were not significantly associated with CDI 
occurrence.
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Chapter 1:  Introduction 
 
 
 Healthcare-associated infections (HAIs) are an important concern for hospitalized 
patients.  These types of infections occur in patients during their healthcare treatment 
for other conditions.  In the past decade, infection prevention research and surveillance 
data have shown that HAIs take a major toll on hospitalized patients.  In one clinical 
setting, up to 10% of patients experience an HAI (Smyth et al., 2008).  An estimated 1.7 
million infections and nearly 100,000 deaths occur per year in United States hospitals 
that are attributed to HAIs (Klevens et al., 2007).  These statistics do not reflect the loss 
of productivity, or wages lost by patients stemming from patient illness and disability due 
to a HAI.   
The Association for Professionals in Infection Control and Epidemiology, the 
Society for Healthcare Epidemiology of America, the Infectious Diseases Society of 
America, the Assocation of State and Territorial Health Officials, the Council of State 
and Territorial Epidemiologists, the Pediatric Infectious Diseses Society and the Centers 
for Disease Control and Prevention (CDC) proposed together a call to action to move 
toward the elimination of HAIs.  Many HAIs are preventable, which led the Centers for 
Medicare & Medicaid Services (CMS) to no longer reimburse hospitals for the extra 
costs associated with certain infections that develop during hospitalization, such as 
infections due to urinary or vascular catheter use after October 1, 2008 (Medicare 
Program., 2008).  Further, HAIs are reported publicly and may have a deleterious effect 
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on an organization’s credibility and accountability.  As of February 2013, 31states 
require public reporting of HAIs and the majority of the rest are proposing such 
legislation (The Association for Professionals in Infection Control and Epidemiology, 
2013; Weinstein & Henderson, 2009).  Mandatory public reporting is intended to allow 
key stakeholders, including the public, to make better healthcare choices. Consumer-
oriented and professional websites are tracking state adoption of HAI reporting, 
including the type of infections reported, whether the data are publicly available, and 
whether hospital identifiers are released to the public (The Association for Professionals 
in Infection Control and Epidemiology, 2013).  
Focus on Clostridium difficile 
The purpose of this research is to focus on Clostridium difficile infection (CDI) for 
several reasons.  First, C. difficile is an important cause of healthcare-associated 
antibiotic-associated diarrhea and colitis. Second, C. difficile is tied with methicillin-
resistant Staphylococcus aureus (MRSA) as the most common organism to cause HAIs 
in the United States (McDonald, Owings, & Jernigan, 2006).  Further, the incidence of 
CDI has been steadily increasing over the past decade, as reflected by the increase in 
the number of International Classification of Diseases, Ninth Revision, Clinical 
Modification codes for CDI.  The ICD-9-CM is a classification system which assigns 
numeric codes to diagnoses for hospital stays. The number of CDI hospital stays 
increased four-fold over the time period from 1993 to 2009 (Lucado, J., Gould, C., 
Elixhauser, A., 2012).  Patients with CDI have a 2.5-fold increase in 30-day mortality as 
compared to similar patients without CDI (Hensgens, Goorhuis, Dekkers, van Benthem, 
& Kuijper, 2013). Third, an emerging hypervirulent strain of C. difficile [currently referred 
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to as North American Pulsed Field type 1 (NAP1) and PCR ribotype 027 (NAP-
1/027)](Kelly & LaMont, 2008) has been identified that is highly transmissible (Pakyz, 
MacDougall, Oinonen, & Polk, 2008) and virulent and has caused epidemics of CDI in a 
large number of institutions throughout North America (Loo et al., 2005; McDonald et 
al., 2005; Warny et al., 2005).  Fourth, the CDC has established CDI as one of three 
types of infections that are at the urgent threat level (United States Department of 
Health and Human Services Centers for Disease Control and Prevention, 2013).  Fifth, 
the management of CDI has been estimated to cost $3.2 billion dollars per year in the 
United States (O'Brien, Lahue, Caro, & Davidson, 2007).  Lastly, CDI may be modifiable 
by patient factors such as antibiotic use (Bignardi, 1998; Blossom & McDonald, 2007; 
Gaynes et al., 2004; Kazakova et al., 2006; Lai, Melvin, Menard, Kotilainen, & Baker, 
1997; Loo et al., 2005; McCusker, Harris, Perencevich, & Roghmann, 2003; Modena, 
Bearelly, Swartz, & Friedenberg, 2005; Muto et al., 2005; Pepin, Saheb et al., 2005) and 
gastric acid suppressant (GAS) agent use (Akhtar & Shaheen, 2007; Al-Tureihi, 
Hassoun, Wolf-Klein, & Isenberg, 2005; Aseeri, Schroeder, Kramer, & Zackula, 2008; 
Dial, Alrasadi, Manoukian, Huang, & Menzies, 2004; Dubberke et al., 2007; Dubberke et 
al., 2008; Jayatilaka et al., 2007; Kazakova et al., 2006; Muto et al., 2005; Parente et 
al., 2003; Scagliarini et al., 2005; Yearsley et al., 2006).  The role that appropriate 
antibiotic and GAS agent use serves in the prevention of CDI occurrence is described 
further below.      
The monitoring of CDI has increased recently at the national level. Beginning in 
2013, hospitals that participate in the CMS Inpatient Prospective Payment System 
Quality Reporting Program were required to report CDI cases using the CDC’s National 
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Healthcare Surveillance Network (NHSN).  Further, public reporting of hospital CDI 
cases will commence in 2014 on the Department of Health and Human Services 
Hospital Compare Website. 
Prevention of Clostridium difficile:  Patient-level Risks 
Many patient-level risk factors for CDI have been delineated from case-control 
and cohort studies.  Non-modifiable risk factors include advanced patient age and 
length of hospitalization, while modifiable risk factors include medication use, such as 
antibiotics  and GAS agents (Howell et al., 2010; Loo et al., 2011; Stevens, Dumyati, 
Fine, Fisher, & van Wijngaarden, 2011).  Receipt of antibiotics is regarded as the main 
modifiable risk factor for healthcare-associated CDI and serves as the primary target for 
antimicrobial stewardship efforts aimed at decreasing CDI occurrence (Valiquette, 
Cossette, Garant, Diab, & Pepin, 2007).  Though most antibiotic classes have been 
associated with CDI, receipt of certain antibiotics, such as clindamycin and 
cephalosporins, may place hospitalized patients at the highest risk for acquiring CDI 
(Owens, Donskey, Gaynes, Loo, & Muto, 2008).  The Society for Healthcare 
Epidemiology of America (SHEA) and the Infectious Diseases Society of America 
(IDSA) CDI Clinical Practice Guideline recommends that the restriction of these agents 
may be particularly helpful in reducing CDI development, though the decision to target 
certain antibacterials should be based on local epidemiology (Cohen et al., 2010).  The 
receipt of fluoroquinolones, especially in settings where the CDI epidemic strain North 
American PFGE type 1 (NAP1) has been implicated, is also considered high-risk. Thus, 
fluoroquinolone use may also serve as a target to direct antimicrobial stewardship 
efforts (Cohen et al., 2010).  Other agents that may be considered high-risk include the 
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broad-spectrum agents, the carbapenems, and β-lactamase inhibitor combinations. 
Though not as consistently as antibiotics, several studies have shown that the use of 
GAS agents, in particular, proton pump inhibitor agents (PPIs), is also a contributing 
factor to development of CDI (Cunningham, Dale, Undy, & Gaunt, 2003; Howell et al., 
2010; Stevens, Dumyati, Brown, & Wijngaarden, 2011; Yearsley et al., 2006).   
Prevention of Clostridium difficile:  Organizational-level Risks 
While many patient-level case-control studies to identify patient risk factors for 
CDI have been conducted, little is known about organizational-level risk factors. The 
Institute of Medicine (IOM) refers to the importance of the organizational-level in 
developing a patient safety culture in its Crossing the Quality Chasm report (Institute of 
Medicine, 2001).  Through an organizational sociology theoretic perspective on 
healthcare organizational change, one can approach such questions as why and how 
healthcare organizations change, and what motivates them to change (Flood & Fennell, 
1995).  By taking an organizational view, this study seeks to address a gap in the 
literature by examining organizational factors that may impact an organization’s 
response to HAIs. Though an organizational perspective has been increasing applied to 
healthcare, there is a paucity of research regarding an understanding of organizational 
influencers that drive organization change in addressing HAIs from an organizational 
perspective.  An organizational perspective can provide insights into the environment in 
which healthcare organizations function and the macro context that influences an 
organization’s strategy (Murray & Holmes, 2012).  Thus, an understanding of these 
factors may aid in understanding the internal and external factors that motivate change 
behavior among healthcare organizations.  The ultimate goal is to identify rational 
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policies and interventions that could lead to a decrease in CDI independent of practices 
by individual clinicians.  Other researchers have found correlations between 
organizational factors and patient infection outcomes, such as the influence of nurse 
staffing on the occurrence of MRSA infections (Haley et al., 1995; Vicca, 1999). 
Conceptual Framework 
The availability of a large data source of CDI cases among a consortium of 
academic health centers affords a framework in which to further understand 
organizational factors related to CDI.  The line of inquiry is to identify organizational 
factors, after controlling for known CDI risk factors, that are associated with a reduced 
incidence of healthcare-associated (HA) CDI.  Institutional theory, as a conceptual 
model, will be used to articulate hypotheses that will be used to analyze organizational 
factors that are associated with reduced HA-CDI.  This is important because many of 
the interventions towards reducing HA-CDI occur at the organizational level, and 
because of the increasing regulatory actions associated with HA-CDI at the healthcare 
organization-level.  This theory views organizational structure as an adaptive organism 
that is influenced by the characteristics of its participants and by its environment (Scott 
W, 2007).  Further, as a response to environmental pressures, organizations will 
exercise strategic choice within the constraints posed by its capabilities and institutional 
environment.   
According to institutional theory, organizations will adopt relevant institutional 
strategies to aid them in achieving legitimacy.  Legitimacy is a resource that can assist 
organizations in acquiring other resources, such as knowledge, and financial and 
intellectual resources (Zimmerman & Zeitz, 2002). In order to maintain legitimacy in an 
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uncertain and demanding environment, organizations will tend to copy the practices of 
similar organizations (Yang, Fang, & Huang, 2007). The concept of ‘institutional 
bandwagons’ has been used to describe the forces of organizations to adopt an 
innovation, not due to an individual evaluation of the innovation, but because of the 
number of other organizations that have previously adopted the innovation 
(Abrahamson & Rosenkopf, 1993).  DiMaggio and Powell have termed the process of 
organizations tending to become homogenous similar under the same environmental 
conditions as isomorphism (DiMaggio & Powell, 1983).   
Healthcare organizations, such as hospitals, comprise a network of institutions 
that deliver acute care within the complex healthcare industry.  Other entities that 
comprise the healthcare industry include other hospitals, long-term care facilities, 
insurers, policymakers, and regulators.  Thus, there are many types of forces acting on 
hospitals stemming from the healthcare environment that impact their decisions in 
regards to adopting or not adopting certain preventative measures to prevent HAIs, 
such as CDI.  
The main constructs from institutional theory that apply to hospital adoption of 
HAI prevention practices are the institutional pressures that play a role in adoption 
intent.  DiMaggio and Powell have described three types of institutional isomorphism:   
coercive; normative; and mimetic (DiMaggio & Powell, 1983).  Coercive isomorphic 
pressures represent authoritative forces, which would include those stemming from 
state government mandates in the form of mandatory regulations for HAI reporting.  
Mimetic isomorphism occurs when organizations copy other organization’s practices in 
times of uncertainty.  Normative pressures stem from those brought about by 
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professional norms; these could be licensure requirements, for example.  Figure 1 
displays how institutional forces will affect the adoption of CDI prevention practices by 
hospitals. 
Figure 1.  Theoretical Model of Isomorphic Pressures Acting on Hospitals  
 
Research Question 
 Given the growing problem of HAI occurrence in hospitalized patients, it is 
important to gain a better understanding of the factors that motivate organizations, such 
as hospitals, to adopt effective prevention efforts to decrease the occurrence of HAIs.  
Towards this goal, this study aims to apply an organization approach to infection 
prevention.  Specifically, the research question (RQ) to be answered is the following:  
RQ:  What are the organizational factors that are associated with HA-CDI in hospitalized 
patients?  
 
          Hospitals  
Mimetic Pressures 
 
 
Normative Pressures 
 
Coercive Pressures 
Coercive Pressures 
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Scope and Approach  
 Administrative claims data were obtained from University HealthSystem 
Consortium (UHC) hospitals, an alliance of academic health centers, for the conduction 
of this study.  A subset of UHC hospitals subscribe to the Clinical Resource Manager 
(CRM) program.  The UHC CRM database is comprised of procedure- and diagnosis-
specific data from discharge abstract summaries and inpatient drug use.  Hospital-level 
data were obtained from aggregated patient-level data on adult patients (≥ 18 years of 
age) discharged from UHC CRM hospitals between January 1, 2011, and December 31, 
2011.  Complete data were available for 89 hospitals. 
Hospital-level analyses will be conducted to ascertain whether there are 
associations between organizational factors that were derived from institutional theory 
and the incidence of HA-CDI in hospitals.  Cases of HA-CDI in hospitals were risk-
adjusted based on factors found to contribute to HA-CDI in hospitals.  Then 
multivariable negative binomial regression models were conducted to test generated 
hypotheses.   
Rationale and Significance 
The occurrence of HAIs in hospitals poses a threat to patient safety.  There are 
increasing pressures on healthcare organizations, such as hospitals, to report, in a 
public manner, information concerning their HAI rates.  Further, there are increasingly 
more policies to forgo payment for complications that occur during the delivery of health 
care that are preventable.  Given the importance for hospitals to decrease HAIs, such 
as CDI, this study potentially offers valuable information regarding the motivating forces 
on hospitals to take action to decrease HA-CDI using an institutional perspective.  The 
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study findings can inform researchers and policymakers on potentially effective 
strategies for reducing HA-CDI among hospitalized patients.   
Summary and Outline of Remaining Chapters   
In summary, this chapter provided an introduction to the research described in 
the dissertation related to prevention of HAI occurrence, in particular HA-CDI.  An 
introduction to the theoretical perspective used in the current research, institutional 
theory, was also provided.  This perspective was used to address the research question 
of which organizational factors are related to HA-CDI in hospitals. Chapter two reviews 
the literature on HA-CDI epidemiology, pathogenesis, diagnosis, risk factors, and 
prevention.  Chapter three presents the theoretical perspective, institutional theory, and 
conceptual model that were used to guide the development of study hypotheses in more 
detail.  Chapter four provides the study methodology, while chapter five presents the 
study results.  Finally, chapter six concludes with a discussion related to study findings. 
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Chapter 2:  Literature Review 
 
 
The occurrence of HAIs is an important safety problem in hospitals.  Healthcare-
associated infections contribute to unnecessary morbidity and mortality; the Centers for 
Disease Control and Prevention (CDC) estimates that 1 out of every 10-20 patients 
hospitalized in the U.S. develops a HAI, resulting in an estimated 100,000 deaths 
(Klevens et al., 2007).  The estimated attributable costs of HAIs in hospitals are equal to 
$28.4 to $33.8 billion in excess medical costs (R. D. Scott, 2009).  Many HAIs are seen 
as preventable adverse events caused by medical errors such as failure to adhere to 
evidence-based prevention strategies.  
Some of the more common HAIs include ventilator-associate pneumonias (VAP), 
MRSA, central line-associated bloodstream infections (CLABSIs), surgical site 
infections, and C. difficile infection.  Given the preventability of many HAIs, the growing 
public concern over HAIs, and the increased national attention on prevention of HAIs, 
more research is needed to discern what organizational factors influence hospitals in 
identifying the need to take specific steps to reduce HAI rates.  Specifically, what kind of 
forces influence them, which ones influence them the most, and what causes them to 
take action towards reducing HAIs.  Acquired knowledge in this field will be beneficial in 
planning future studies related to the development and adoption of strategies to 
decrease the occurrence of HAIs. 
  12 
Focus on C. difficile Infection 
 Clostridium difficile infection is a potentially serious HAI; it is the most common 
cause of infectious diarrhea in hospitalized patients.  Being diagnosed with CDI results 
in a threefold increase in the risk of death during hospitalization, with patients older than 
age 65 conferring the greatest risk (Oake et al., 2010).  There has been a change in the 
epidemiology of CDI since 2000; reports suggest that there has been an increase in the 
number of CDI cases that are treatment failures to metronidazole, that relapse after 
treatment of CDI, and that cause severe disease/complications such as toxic 
megacolon, perforation, colectomy, shock and death (Blossom & McDonald, 2007; 
Kazakova et al., 2006; Musher et al., 2005; Pepin, Alary et al., 2005; Ricciardi, 
Rothenberger, Madoff, & Baxter, 2007).  More worrisome is the recent identification of 
an emerging strain of C. difficile that hyperproduces toxins A and B, is highly 
transmissible and has caused epidemics of CDI in a large number of institutions 
throughout North America (Loo et al., 2005; McDonald et al., 2005; Warny et al., 2005).  
The change in CDI epidemiology is attributed to this epidemic strain of C. difficile as well 
as to changes in host immune systems, and in antibiotic prescription practices and other 
medications (McDonald et al., 2006).   
The number of patients who have been discharged from short-stay, acute care 
healthcare facilities who received the International Classification of Diseases, Ninth 
Revision (ICD-9-CM) discharge diagnosis code for CDI increased from 5.6 
hospitalizations per 1,000 adult discharges in 2001 to 11.5 in 2010, with a projected 
increase in the rate to12.5 in 2011 and 12.8 in 2012 (Agency for Healthcare and 
Research and Quality, 2012).  The CDC estimates that 250,000 cases of CDI occur per 
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year which require hospitalization, or affect already hospitalized patients.  A total of 
14,000 deaths per year are attributed to CDI (United States Department of Health and 
Human Services Centers for Disease Control and Prevention, 2013).  Clostridium 
difficile infection is perceived to constitute a major economic impact and is a major 
financial drain (Dubberke & Wertheimer, 2009).  Among patients hospitalized with CDI, 
their average age is 68, signifying that their inpatient stays are billed to Medicare the 
majority of the time, which contributes to the increase in Medicare costs nationally (J. 
Lucado, Gould, & Elixhauser, 2006) .   
As of 2013, hospitals that participate in CMS’s Hospital Inpatient Quality 
Reporting Program (QRP) are required to report CDI cases using the CDC’s National 
Healthcare Surveillance Network.  Public reporting of hospital CDI cases will commence 
in 2014 on the Department of Health and Human Service’s Hospital Compare Website 
(The Centers for Medicare & Medicaid Services, 2013). The CMS will begin to collect 
data on hospitals’ incidences of CDI for use in its fiscal year 2015 hospital inpatient 
QRP for inclusion in the agency’s Value-based Purchasing (VBP) Program, which was 
mandated by The Patient Protection Affordable Care Act in October 2012.  Under this 
program, baseline Diagnosis-related group (DRG) payments may be withheld (up to 1% 
in year one of program) depending upon hospital performance on a variety of quality 
indicators, including infections.  In addition to CDI, hospitals must begin to report MRSA 
infections in January 2013. The reporting of these infections is in addition to the 
reporting of CLABSIs, catheter-associated urinary tract infections (CAUTIs), and 
infections from colon and abdominal hysterectomy, which convened prior to 2013.   
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Pathogenesis   
Clostridium difficile infection is a common complication of hospitalization causing 
infectious diarrhea (Blossom & McDonald, 2007).  Patients ingest either C. difficile 
spores or vegetative organisms obtained from the healthcare environment or from 
hands of healthcare workers who have touched contaminated items or surfaces; 
subsequently the spores germinate in the colon and change to the vegetative form. 
Toxin-producing strains secrete toxins A and B, which lead to production of tumor 
necrosis factor, pro-inflammatory interleukins, and increased vascular permeability 
(Blondeau, 2008).  If infected, patients experience abdominal symptoms and diarrhea, 
and can also have dehydration.  Potentially more serious complications include toxic 
megacolon and pseudomembranous colitis, a potentially lethal inflammatory condition 
that can lead to perforation of the colon.  Symptoms of CDI can occur at any time during 
a course of antibiotic treatment--one of the main risk factors to developing CDI--for up to 
8 weeks following antibiotic discontinuation (Hurley & Nguyen, 2002).  The use of the 
two main treatment agents for CDI, metronidazole and oral vancomycin, facilitates 
recurrent infection, usually occurring within four weeks, by impairing resistance to 
colonization of C. difficile. Recurrence rates after treatment with metronidazole have 
been reported at 20%, and similarly with oral vancomycin treatment at 18.4% (Kelly & 
LaMont, 2008).    
Diagnosis   
Stool culture for and identification of a toxigenic C. difficile isolate in patients 
experiencing three or more unformed stools in 24 or fewer hours is considered the gold 
standard for CDI diagnosis; however, this testing strategy is not clinically practical due 
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to the time (up to 7 days) and microbiology expertise it takes to perform the test (Cohen 
et al., 2010).  Another laboratory stool analysis test for CDI is the enzyme immunoassay 
(EIA) test for toxin A and B.  This is a rapid test, but it is the least sensitive available 
test; EIA sensitivities may be as low as 60% and are rarely above 90% (Wilcox, 
Planche, Fang, & Gilligan, 2010).  The cell culture cytotoxicity assay, which detects 
toxin B, is more sensitive than the EIA test, but this test is also less sensitive than the 
gold standard, and the assay is technically demanding with a turnaround time of up to 
two days (Bartlett & Gerding, 2008).  The sensitivity of the toxin EIAs and the cell 
cytotoxicity assays can be improved by performing a two-step algorithm method that 
uses EIA detection of glutamate dehydrogenase (GDH) for an initial screen followed by 
a more specific  test such as a cell cytotoxicity assay, a toxin A/B EIA, or a molecular 
assay.  Molecular methods, such as polymerase chain reaction (PCR) testing are the 
most sensitive and specific tests available.  Hospital laboratories that use molecular 
tests may have twice the detection rate of CDI than laboratories using other tests (Fong 
et al., 2011).  From CDI rate data reported by the CDC’s NHSN in 2010, 35% of 
reporting hospitals were using molecular tests (McDonald et al., 2012). The type of CDI 
testing methodology used can influence the speed as well as the amount of CDI cases 
detected, with a PCR method detecting more cases at a faster rate as compared to 
toxin EIA and two-step testing methods (Grein J, Ochner M, Jin A, Hoang H, Morgan M, 
Murthy R, 2011).   
Risk Factors - Drugs 
Clostridium difficile infection occurs almost entirely in patients who are receiving 
or have recently received antibiotic treatment.  Administration of antibiotics alters the 
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indigenous microflora of the colon, allowing for the growth of C. difficile in high 
concentrations and proliferation of toxin-producing C. difficile (Owens et al., 2008). The 
cumulative dose, number, and duration of antibiotics have all been independently 
associated with the development of CDI, with higher exposure levels conferring the 
greatest risk (Stevens et al., 2011).  Antibiotic use increases the risk for CDI 
development by seven- to ten-fold during the time the antibiotic is being taken and for 
one month after, and by nearly three-fold for two months after (Hensgens, Goorhuis, 
Dekkers, & Kuijper, 2012).  While any antibiotic can promote CDI, broad-spectrum 
antibiotics such as cephalosporins, beta-lactamase inhibitor combinations, 
fluoroquinolones, and the agent clindamycin are associated with the greatest risk 
(Owens et al., 2008). The use of gastric acid suppressant agents (GAS), such as proton 
pump inhibitors (PPIs) and histamine-2 receptor antagonists may also augment the 
incidence of CDI (Akhtar & Shaheen, 2007; Al-Tureihi et al., 2005; Aseeri et al., 2008; 
Dial et al., 2004; Dubberke et al., 2007; Jayatilaka et al., 2007; Kazakova et al., 2006; 
Muto et al., 2005; Parente et al., 2003; Scagliarini et al., 2005; Yearsley et al., 2006).  A 
meta-analysis of the studies that examined GAS use and the development of CDI 
obtained a pooled odds ratio of 1.94 (CI: 1.37-2.75) with GAS use (Leonard, Marshall, & 
Moayyedi, 2007).   A possible mechanism is that while C. difficile spores are generally 
acid resistant, the vegetative form of C. difficile can survive on moist surfaces and in 
gastric contents at an elevated pH caused by excess use of agents such as PPIs, while 
normally vegetative C. difficile cells are rapidly killed at normal gastric pH (Jump, Pultz, 
& Donskey, 2007).  A dose response effect has been documented for PPIs and the risk 
of CDI (Howell et al., 2010).  Further, in 2011, the U.S. Food and Drug Administration 
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added a drug safety statement concerning PPI use and risk of CDI in package labeling 
(U.S. Food & Drug Administration, 2011).  Besides antibiotic and GAS agents, 
chemotherapeutic drugs have been associated with CDI; this may be due to antibiotic 
properties of some chemotherapeutic agents and also due to their immunosuppressive 
side effects (Cohen et al., 2010; McFarland, Mulligan, Kwok, & Stamm, 1989). 
Risk Factors - Direct Transmission  
Clostridium difficile is shed in the feces; the main mode of CDI transmission is 
through the fecal-oral route (Cohen et al., 2010). Transmission between patients occurs 
when patients ingest C. difficile organisms obtained from contaminated surfaces or from 
hands of healthcare workers who have touched contaminated surfaces.  The main 
reservoirs of C. difficile are contaminated surfaces and colonized or infected patients.  
Estimates of C. difficile colonization in stool among asymptomatic patients in hospitals 
range widely, from 7.0%-26% (Cohen et al., 2010).  Clostridium difficile colonization 
pressure, or the risk of contracting CDI from surrounding colonized or infected patients, 
defined as the sum of a patient’s daily exposure to patients with CDI who share the 
same unit or ward divided by patient’s length of stay risk, has been found to be an 
independent risk factor for CDI (Dubberke et al., 2007).  Further, patients with CDI that 
was acquired before a hospital admission, but who present to the hospital with CDI, 
community-onset (CO) CDI, can serve as a source of transmission.  It has been shown 
that the prevalence of CO CDI, defined either as having a positive C. difficile specimen 
within 48 hours prior to or after inpatient admission, can increase the incidence of HA-
CDI in a hospital by 3.0% (Zilberberg et al., 2011).   
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Risk Factors - Patient Demographics 
Advanced patient age, in particular, ages 65 years or older,(McDonald et al., 
2006; Pepin et al., 2004) having a history of hospitalization within the previous 60 
days,(Dubberke et al., 2007) the duration of hospitalization, (McFarland et al., 1989) 
and having an intensive care unit (ICU) stay(Riddle & Dubberke, 2009) during 
hospitalization have all been associated with CDI occurrence.  Having an 
immunosuppressing condition such as human immunodeficiency virus (HIV), having 
undergone a solid organ or stem cell or bone marrow transplant or a gastrointestinal 
surgery is also associated with increased CDI risk (Collini, Bauer, Kuijper, & Dockrell, 
2012; Sanchez et al., 2005; Thibault, Miller, & Gaese, 1991). The hospital admission 
source of patients should also be considered when assessing patient risk factors for 
CDI; specifically, admittance from a long-term care facility or another hospital should be 
considered.  A national point prevalence study found that among 1,143 patients 
hospitalized with CDI among 648 hospitals, 35% of them had been admitted to a long-
term care facility within 30 days before hospitalization, while 47% of the patients had 
been previously hospitalized within 90 days (Jarvis, Schlosser, Jarvis, & Chinn, 2009).  
Risk Factors - Hospital-level 
There are a few published studies that have examined risk factors at the hospital-
level.  Chandler and colleagues (Chandler, Hedberg, & Cieslak, 2007) evaluated 
hospital-level characteristics (licensed bed capacity, number of intensive care units, 
number of operating rooms, and presence of hemodialysis units, hematology or 
oncology wards, and long-term care beds) associated with increases in CDI rates 
among 48 Oregon hospitals from 1995 to 2002.  Policies for laboratory testing of C. 
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difficile, such as the testing method used (cytotoxin assay, bacterial culture or EIA) were 
evaluated.  Infection control policies were also assessed, such as whether there were 
isolation precautions, a requirement of private rooms for patients with CDI, whether 
gloves and gowns were used by healthcare personnel, and what disinfectant agents 
were used for environmental cleaning.  The results showed that hospitals with more 
than 250 beds and more than five ICU beds had higher rates of CDI.  Hospitals that 
served more populated regions had the highest increase in CDI rates.  None of the 
hospital infection control policies were associated with increases in CDI rates. The 
authors also evaluated antibiotic policies from 41hospitals, including the formulary 
status for eight antibiotics; actual antibiotic use was not measured.  No specific 
antibiotics with open formulary status were significantly associated with increasing rates 
of CDI.  
Van der Kooi et al. (van der Kooi et al., 2008) examined the relationship between 
hospital aggregate antibiotic use and the incidence of CDI caused by the CDI epidemic 
strain, PCR ribotype 02, among 23 hospitals in the Netherlands.  Antibiotics associated 
with CDI included second-generation cephalosporins and total antibiotic use.  Among 
the five hospitals with occasional incidences of the epidemic strain, three of them were 
academic hospitals and these hospitals had significantly higher second-generation 
cephalosporin use as well as higher extended-spectrum penicillin use.   
Gilca and colleagues (Gilca, Hubert, Fortin, Gaulin, & Dionne, 2010) examined 
hospital factors related to an increased incidence of CDI in epidemic and non-epidemic 
periods among 83 acute care hospitals that had at least 1,000 discharges per year in 
Quebec, Canada, from 1998 to 2006.  Across both epidemic and non-epidemic periods, 
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the results were similar.  A larger hospital bed size, a longer length of hospital stay, a 
greater proportion of elderly patients, a greater number of comorbidities among patients, 
and certain geographic regions (proximity to Montreal) were all associated with an 
increased incidence of CDI.  A teaching profile was associated with a decreased 
incidence of CDI.   
Prevention 
The Infectious Diseases Society of America and the Society for Healthcare 
Epidemiology of America (IDSA/SHEA) have published clinical practice guidelines for 
CDI (Cohen et al., 2010).  One component of the guidelines is the infection control 
measures that should be implemented, especially in an outbreak situation, such as 
enhanced cleaning of patient care areas with 10% sodium hypochlorite, hand washing 
with chlorhexidine or soap and water, and use of both gowns and gloves when taking 
care of patients with CDI.  Further, compliance to hand hygiene practices is 
encouraged.  Other infection control measures such as prompt identification of patients 
with CDI through electronic alerts and single rooms or patient cohorting for CDI patients 
may also aid in containing CDI outbreaks (Gerding, Muto, & Owens, 2008).  Another 
component of these guidelines is the recommendation to implement an antimicrobial 
stewardship program to lower the frequency and duration of antimicrobial therapy and 
the number of agents prescribed to lower the risk of CDI.   
Implementation of interventions to reduce CDI in single-center studies have 
resulted in CDI rate reductions(Carling, Fung, Killion, Terrin, & Barza, 2003; Climo et al., 
1998; Khan & Cheesbrough, 2003; McNulty, 1997; Muto, Blank, Marsh, Vergis, O Leary 
et al., 2007; Pear, Williamson, Bettin, Gerding, & Galgiani, 1994; Valiquette et al., 
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2007).  For example, after implementation of an antibiotic stewardship program in one 
institution designed to decrease the use of antibiotics associated with a CDI outbreak 
(third-generation cephalosporins, clindamycin, and fluoroquinolones) there was a 
significant reduction in the incidence in CDI (Valiquette et al., 2007).  Muto and 
colleagues (Muto, Blank, Marsh, Vergis, O'Leary et al., 2007) were able to control a CDI 
outbreak due to the BI strain by institution of a comprehensive “bundle,” or multifaceted, 
approach towards controlling CDI whereby several measures were implemented 
targeted at CDI reduction, such as restriction of use of high-risk agents such as 
levofloxacin and ceftriaxone, development of a CDI management team, and expanded 
infection control measures.  A collaborative CDI Intervention Program with a focus on 
the implementation of CDI standardized infection control measures among New York 
Metropolitan Regional hospitals has also been associated with a significant reduction in 
HA-CDI rates among participating institutions (Koll et al., 2013).  
Though many institutions have increased their number of CDI prevention efforts, 
they are not always resulting in great improvements.  According to the results from the 
Pace of Progress study conducted by the Association for Professionals in Infection 
Control and Epidemiology, among 14,000 members in January, 2013, a total of 70% of 
survey respondents reported that their hospital had adopted additional intervention 
towards CDI prevention since March 2010 (Association for Professionals in Infection 
Control and Epidemiology, 2013).  However, only 42% of respondents reported a 
decrease in CDI during that time period. 
 This chapter provided a review on CDI epidemiology, diagnosis, treatment, 
prevention, and risk factors, both individual and organizational.  Further, this review 
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provides the background in which to understand the factors that lead to HA-CDI 
development among patients and information concerning the types of strategies that 
hospitals can adopt in order to decrease HA-CDI.  Chapter three will describe the use of 
institutional theory, the perspective used to generate hypotheses, to ascertain 
organizational factors that may influence whether hospitals take action to decrease HA-
CDI.  Further, chapter three presents the developed hypotheses and provides a 
conceptual framework for the research question.  The hypotheses that were generated 
to be tested were designed to aid in the identification of the factors that contribute to the 
differing rates of HA-CDI among hospitals.  
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Chapter 3:  Theoretical Framework and Conceptual Model 
 
 
Despite the availability of evidence-based guidelines and examples of successful 
practices to decrease HA-CDI, this infection type remains an infection prevention target 
for hospitals.  A better comprehension of contributing factors in hospitals is needed in 
order to identify why certain hospitals have lower rates compared to other hospitals.  
Further, in order to inform organizational-level policy, it is important to ascertain what 
factors have been specifically associated with reductions in HAIs. In studying 
organizational response to HAIs, it is useful to look at the ways hospitals, in general, 
respond to changes in their environment.  Organizational theory can be used to predict 
or explain the strategic approach that may be taken by organizations when they are 
faced with threats to patient safety, as in the case of HA-CDI.   
While there is a dearth of studies assessing the problem of HAIs using an 
organizational theory perspective, this view may offer insights to the motivating factors 
that drive behavior in healthcare organizations, such as hospitals.  Specifically, the 
organizational theory perspective of institutional theory can serve as a useful framework 
in guiding the development of study hypotheses related to ascertaining the internal and 
external organizational factors that may impact on HA-CDI rates in hospitals.  In the first 
part of this chapter, a review of the institutional perspective, institutional theory, is 
presented.  Then a conceptual model of the research study is presented, followed by a 
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review of the organizational factors related to HA-CDI occurrence in hospitals and the 
proposed hypotheses.   
Institutional Theory 
Above all, institutional theory posits that an organization aims to ensure its 
survival.  Achieving legitimacy and political power is important to its survival as a means 
to having access to resources (Scott, 2007).  Though institutionalization has been 
defined in several ways by various theorists, a common theme is that institutionalization 
is a social process.  Through this process, individuals begin to accept a shared 
definition of social reality that is independent of the individual’s views, but is taken for 
granted as “the way things are to be done” (Scott, 1987).  As per Meyer and Rowan, for 
example, the shared belief system, or rational myths, of an institution can aid in 
explaining the existence of organizational structure.  The role of cultural elements, such 
as normative beliefs and symbols, is emphasized (Scott, 1987).  By adopting a set of 
shared beliefs, organizations do so in order to increase their legitimacy and their 
survival capabilities (Meyer & Rowan, 1977).   
One of the earliest versions of institutional theory was developed by a sociologist, 
Philip Selznick.  According to Selznick, the institutional perspective examines the 
emergence of distinctive forms, processes, and strategies that evolve from patterns of 
organizational interaction and adaption in response to the internal and external 
environment (Selznick, 1948).  From this perspective, “to institutionalize” means to 
“infuse with value beyond the technical requirements of the task at hand” (Scott, 1987).  
Further, through institutionalization and the instilling of value, this promotes persistence 
of the structure over time (Selznick, 1948).   
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A subsequent variant of institutional theory was developed by Meyer and Rowan 
(1977).  According to these authors, the institutionalization of organizational techniques, 
services, policies, and programs or institutional rules, serve as powerful myths that 
organizations will adopt ceremonially, thereby establishing ‘rationalized myths”(Meyer & 
Rowan, 1977).  Rationalized myths become highly institutionalized and taken for 
granted as legitimate.  By adopting rules, organizations seek to obtain legitimacy, 
resources, stability, and a greater chance of survival.  Because organizational aspects 
that are adopted ceremonially are not necessarily in congruence with efficiency criteria 
(Meyer & Rowan, 1977), organizations that adopt institutional rules in order to maintain 
ceremonial conformity, and in order to achieve legitimacy, become loosely coupled.  
That is, organizations will decouple formal structures from the technical core to maintain 
legitimacy and organizational effectiveness (Meyer & Rowan, 1977).   
Legitimacy 
The main tenet of institutional theory is that organizations will adopt relevant 
institutional strategies to aid them in achieving legitimacy.  Legitimacy is a resource that 
can assist organizations in acquiring other resources, such as knowledge, and financial 
and intellectual resources.  Achieving legitimacy will guarantee having access to 
resources and support allowing survival due to the status granted by adopting 
institutional norms (Meyer & Rowan, 1977). The concept of ‘institutional bandwagons’ 
has been used to describe the forces of organizations to adopt an innovation, not due to 
an individual evaluation of the innovation, but because of the number of other 
organizations that have previously adopted the innovation (Abrahamson & Rosenkopf, 
1993). Therefore, institutional theory differs from theories that focus on the place of 
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competition and resources, as it emphasizes factors in an institutional environment, 
such as professional groups and their influences in contributing to the legitimacy and 
performance of an organization (DiMaggio & Powell, 1983).  Researchers (Meyer & 
Rowan, 1977; Zimmerman & Zeitz, 2002) have described a process whereby 
organizations adopt a set of shared normative beliefs in order to increase their 
legitimacy and their survival capabilities.  Yielding to expectations and accepted norms 
from the institutional environment results in legitimacy and stability. In order to maintain 
legitimacy in an uncertain and demanding environment, organizations will tend to copy 
the practices of similar organizations (Yang et al., 2007). The pressures to conform to 
institutional forces can lead to the homogeneity of organizational form, or isomorphism 
(DiMaggio & Powell, 1983).  Thus, organizations become isomorphic with their 
institutional environment to increase legitimacy, reduce uncertainty and increase 
standardization.   
Isomorphism 
The three general mechanisms of isomorphism are mimetic, normative and 
coercive isomorphism.  Mimetic isomorphism occurs when organizations respond to 
practices or norms in the organization’s institutional field and copy what appear to be 
successful organizations (Yang et al., 2007).  Coercive isomorphic pressures represent 
authoritative forces, which would include those stemming from state and federal 
government mandates in the form of mandatory regulations.  Normative isomorphic 
pressures represent forces deriving from professional and occupational groups.  These 
include pressures to conform to values of powerful interest groups (Yang et al., 2007).  
These can also include values and expectations from society-at-large. These pressures 
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are often evident in times of uncertainly for an organization, thus organizations will copy 
what has been successfully accomplished among other organizations (Flood & Fennell, 
1995).   
The isomorphic forces represent the types of influencers that organizations must 
respond to and that impact organizational change.  DiMaggio and Powell (1983) note 
that isomorphic processes occur even in the absence of evidence that they increase the 
efficiency of the organization, calling it the ‘iron cage.”  That is, the reasons for acting on 
the forces is unclear because the organization is an iron cage, imprisoned by 
isomorphic pressures, a state where there is decoupling of structure and efficiency.  As 
Zucker (Zucker, 1987) points out, these forces influence the organization to be guided 
by ‘legitimated elements’ such as those influenced by professional certification or 
mandated by the state as opposed to task performance.  Also adoption of the 
legitimated elements leads to isomorphism within the institutional field and increases 
survival probability.  Adoption of processes and conformity influenced by mimetic, 
coercive, and normative forces increases the availability of resources. Through these 
processes, routines become embedded and hard to change and through 
institutionalization, stability is obtained.  The reason for acting on the forces is unclear 
because the organization is in an iron cage, where there is decoupling of structure and 
efficiency (DiMaggio & Powell, 1983).  Thus, institutional theory does not describe 
processes that make organizations more efficient, but only what forces make 
organizations more similar.  That is, there is a focus on the institutional, as opposed to 
the technical environment, and less emphasis on competitive or organizational 
performance responses (DiMaggio & Powell, 1983). 
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To summarize, Institutional theory is a natural, ecological perspective that takes 
into account that organizations are not isolated from the environment, but are 
interdependent with the environment for staff, resources, and relevant information.  
From this perspective, organizations are subsets of a larger system of relations; 
organizations contain social systems that have differing interests (Scott, 2007).  
Through the process of isomorphism, organizations become more homogenous in 
structure over time (Scott, 2007).  The three institutional forces that lead to homogeneity 
described by institutional theorists include coercive, mimetic, and normative forces.  
Responding to these forces can enhance an organization’s legitimacy and increase their 
ability to obtain valuable resources.  Further, by an institutional perspective, there exists 
a distinction between an institution’s technical and institutional environment.  Thus, 
organizational researchers can use the institutional perspective to study the processes 
by which an organization makes structural changes in order to conform to an 
institutional pattern (Scott, 1987).   
Conceptual Model 
Though there is a dearth of data regarding the organizational factors associated 
with HAIs using an institutional perspective, institutional theory has been applied by 
researchers previously to study why healthcare organizations have changed or 
innovated, or adopted innovations, due to motivating institutional forces. That is, there 
are examples that depict the types of isomorphic pressures or forces to which 
healthcare organizations respond to.  For example, isomorphic forces have been used 
to describe the influencing factors leading to the adoption of Total Quality Management 
(TQM) by hospitals, in particular, the increase in conformity to normative TQM 
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processes over time (Westphal, Gulati, & Shortell, 1997).  Other examples from the 
literature are provided below.   
As discussed above, the three main types of coercive pressures are coercive, 
mimetic and normative.  Coercive pressures represent those forces that are mandated 
by law, or encouraged by accrediting bodies.  Major sources of coercive power acting 
on healthcare organizations are state and government agency policies.  For example, 
changes in Medicaid reimbursement policies have been shown to impact the number of 
specialty care in nursing care facilities (Banaszak-Holl, Zinn, & Mor, 1996).  A state 
Certificate of Need (CON) program was shown to impact the rate of hospital entry into 
management contract arrangements (Alexander & Morrisey, 1989).  Changes in 
Medicare hospital reimbursement policies, such as the prospective payment system 
(PPS) have also been shown to impact hospital behavior.  Implementation of Medicare 
PPS has resulted in hospital expansion of outpatient services such as in the form of an 
increase in ambulatory surgery centers and free-standing emergency centers (Updaw, 
1987).  After PPS was in effect, it has also been noted that the use of technology 
changed in hospitals; there was less ordering of routines tests and certain procedures 
such as the pyelogram, and a decline in non-surgical procedures was also seen (Sloan, 
Morrisey, & Valvona, 1988). 
Organizations operate in a realm of bounded rationality and there exists 
pressures within the organization to respond to mimetic isomorphic pressures, 
espeically in an uncertain situation, by copying other successful organizations 
(DiMaggio & Powell, 1983).  Under institutional theory, groups of organizations that 
operate under the same regulatory scheme comprises an organizational field.  
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Organizations within a field will interact with each other more than organizations outside 
of the field (Noir & Walsham, 2007).  It has been shown that the level of hospital 
community orientation within a  geographic area increaes a hospital’s likeliness to also 
adopt a community orientation (Proenca, Rosko, & Zinn, 2000).  The influence of the 
diffusion of hospitals adopting community orientation activities such as health promotion 
programs has also been shown to impact a hospital’s likeliness to implement community 
oriented activities (Ginn, Shen, & Moseley, 2009).  Another example of a mimetic force 
influencing adoption among healthcare organizations, includes the positive influencing 
factor of the number of hospitals having provider-based Rural Health Clinics in a state 
on a hospital’s disposition to also adopt a provider-based Rural Health Clinic (Krein, 
1999). 
Other types of pressures facing healthcare organizations are normative forces.  
Normative pressures are present through forces originating from the professionalization 
of members who serve as powerful interest groups, or from specialization processes.  
Normative isomorphism implies that practicing certain professional standards is 
voluntary and depends on professional agents’ knowledge (Yang et al., 2007).  
Professional agents have access to external knowledge in the relevant professional field 
(Tsai, 2001).  DiMaggio and Powell (1983) refer to professionalization as the defining of 
the conditions and methods by professionals of their work in order to establish a 
cognitive base and to legitimize their autonomy.  Thus, normative forces stem from the 
organization’s professional groups to adopt forms or processes that are their 
profession’s norms.  Physicians have been the primary source of normative pressures 
in healthcare, but there has also been an increasing influence from other professional 
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groups, such as allied professionals and professional managers (Flood & Fennell, 
1995).  It has been shown that the greater the degree of support for human 
immunodeficiency virus (HIV) prevention practices by clinical supervisors among 
outpatient drug abuse treatment units, the greater the extent of the adoption of HIV 
prevention practices, such as condom distribution and HIV antibody testing (D'Aunno, 
Vaughn, & McElroy, 1999).   
As organizational practices become institutionalized, they can become 
institutional ‘rationalized myths’ whereby a presumption is made that they are true 
because of widespread belief in them (Scott, 2007).  The practices are adopted 
because of the perceived gains in legitimacy and survival benefits from conforming to 
widely held expectations rather than for an efficiency gain (DiMaggio & Powell, 1983).  
Per the institutional theory perspective, there exists a distinction between an 
organization’s technical core and institutional demands. This decoupling process occurs 
so that organizations can maintain their external legitimacy and still be efficient; this 
process can affect the structure within an organization (Meyer & Rowan, 1977).  That is, 
the adoption of certain practices can convey a legitimate external appearance; however, 
the full implementation of the practices may not be implemented within the organization.  
For example, it has been shown that while healthcare agencies had adopted case 
management in order to increase service coordination among centers providing HIV 
patient services – as it had become a normative institutional feature – there were 
actually very little operational connections between different agencies (Benson & 
Kenneth, 1981).   
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Hospitals are the unit of focus for this research study; hospitals are members of a 
network of institutions that deliver acute care within the complex healthcare industry.  
Hospitals interact with providers, other hospitals, professional organizations, nursing 
homes, patients, insurers, regulators, policymakers, politicians, and the community, 
among others, in delivering care to patients.  By these interactions, there are forces and 
influences that can potentially influence hospitals’ decisions to adopt certain measures 
to prevent HAIs, such as CDI.   
One of these influencing isomorphic forces is coercive isomorphism.  Coercive 
isomorphic pressures represent authoritative forces, which in the area of HA-CDI would 
include those arising from state government mandates in the form of mandatory 
regulations for HAI reporting, or from the governmental agency, CMS.  For example, 
there are HAIs other than CDI, such as CLABSIs and CAUTIS, which are no longer 
reimbursed by CMS when they occur during a hospitalization.  A no-payment CMS 
policy for some types of infections, but not others, may also impact on the occurrence of 
HA-CDI.  
Another influencing isomorphic type in the areas of HAIs is mimetic isomorphism. 
This process occurs when organizations face environmental uncertainty or ambiguous 
goals and imitate the practices of other organizations that are viewed as more legitimate 
or successful.  Through mimetic isomorphism, organizations within a field, and given 
similar environmental circumstances, will make themselves similar as they make 
changes.  Thus, the organization will be deemed as legitimate as it appears similar to 
hospitals within the same field (DiMaggio & Powell, 1983).  In the area of HAIs, there 
exists state-led multihospital CDI collaboratives.  The goal of these collaboratives is to 
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share data and prevention practices concerning CDI and to institution prevention 
practices across hospitals, with the aim of reducing CDI.    
Other types of pressures facing healthcare organizations are normative forces.  
Normative forces arise from professionalization.  An organization’s professional groups 
may influence the adoption of processes aimed to decrease HA-CDI.  In the area of HA-
CDI, professional groups such as nurses and CDI physician experts could potentially 
impact the quality of patient care, and serve as physician champions in the area of HA-
CDI prevention, respectively.   
Finally, there potentially exists the presence of rationalized myths that may be 
associated with HA-CDI.  For example, there are several hospital scoring systems in 
terms of quality and safety that are based in a large part on process measures and a 
hospital’s reputation in certain areas.  Though a high score on these scoring systems is 
meant to signify a safe hospital that delivers a high level of quality care, it is possible 
that the score does not fully represent aspects of the delivery of safe and quality care at 
the level of an institution’s technical environment.  Figure 2 below depicts the 
conceptual model of this research study, which uses an institutional theory perspective 
to guide the development of study hypotheses related to identifying associations 
between differing institutional forces and HA-CDI occurrence.  
Development of Hypotheses 
Coercive pressures. 
One coercive pressure acting upon hospitals in the area of HA-CDI is the 
regulatory pressure in the form of required reporting, or state-mandated requirements 
for conformity.  There are six states (CA, IL, NY, OR, TN, UT) that require public  
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Figure 2.   Conceptual Model:  Factors Influencing Decisions to Take Action to 
Decrease HA-CDI Using an Institutional Theory Perspective 
 
 
 
 
 
 
 
 
reporting of facility-wide, laboratory-identified CDI (LabID), as of July 2012 (McDonald et 
al., 2012).   
The purpose of HAI public reporting is to spur hospitals to take efforts to prevent 
the occurrence of infections by increasing accountability.  A review published in 2005 
conducted by the Healthcare Infection Control Practices Advisory Committee (HICPAC) 
found no published information regarding the effectiveness of public reporting in 
reducing HAIs.  Thus, HICPAC concluded that there was insufficient evidence to 
recommend for or against HAI public reporting (McKibben, Fowler, Horan, & Brennan, 
2006).   Since publication of the HICPAC review, it has been show that in Ontario, 
Canada, public reporting of hospital rates of CDI resulted in lower than predicted rates 
of infection (Daneman, Stukel, Ma, Vermeulen, & Guttmann, 2012).  Thus, it is 
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hypothesized that coercive forces in the form of mandatory state reporting of HA-CDI 
will result in decreased HA-CDI rates, leading to hypothesis one:  
Hypothesis 1:  Study hospitals that are located in states with mandatory CDI reporting 
will have lower rates of HA-CDI than study hospitals not located in states with 
mandatory CDI reporting. 
A second source of coercive pressures is the looming regulatory pressure acting 
on hospitals in the form of inclusion of HA-CDI in CMS’s 2015 hospital inpatient Quality 
Reporting program (QRP) for addition to the Value Based Purchasing (VBP) program.  
This would affect nearly all hospitals since most hospitals participate in CMS’s QRP.  
Since October 2008, CMS has no longer reimbursed hospitals for extra costs 
associated with conditions that develop during hospitalization, including certain 
infections that develop during hospitalization, such as infections due to catheter-
associated urinary tract infections (CAUTIs) or central line-associated bloodstream 
infections (CLABSIs).  Further, the standardized infection ratios (SIRs) of both CAUTIs 
and CLABSIs are reported for individual hospitals on the U.S. Health and Human 
Services Hospital Compare Website (The Centers for Medicare & Medicaid Services, 
2013).  Thus, while potential payment penalties are looming in the case of CDI, other 
HAIs such as CLABSIs and CAUTIs, have been included on the non-payment list for 
several years.  Lee and researchers (Lee et al., 2012) studied the impact of the CMS 
payment policy on infection prevention efforts and found that infection preventionists 
reported an increase in HAI prevention efforts at their hospitals, but found that resource 
shifting occurred (less time spent on non-targeted HAIs), especially in large hospitals.  
Lee and colleagues (Lee et al., 2012)  demonstrated that the effect of non-payment for 
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certain conditions that develop during hospitalization by CMS had no effect on central 
line-associated bloodstream infections and catheter associated urinary tract infections , 
as compared to a third infection control group, ventilator-associated pneumonia.  They 
attributed their findings to a downward trend for these infections that began years before 
implementation of the CMS policy and potentially a low incentive to decrease HAIs due 
to a small financial stake.  Further, they also found that the policy had no effect in the 
subset of hospitals located within states with no mandatory reporting of HAIs, a group of 
hospitals that may be more motivated by the CMS policy (Krein, Kowalski, Hofer, & 
Saint, 2012).  It appears that whether driven by CMS payment policies or other HAI 
prevention initiatives, hospitals have been focused on two specific HAIs: CLABSIs and 
CAUTIs.  By focusing on CMS-monitored infections, hospitals can seek to gain 
legitimacy through a good performance in their HAI rates, which are reported on a 
public Website, though it may come at the expense of higher HA-CDI.   In the study 
year of 2011, HA-CDI was a CMS non-monitored infection, while CLABSIs and CAUTIs 
were monitored.  This leads to hypotheses 2 (a) & (b): 
Hypothesis 2(a):  Study hospitals that have lower rates of CLABSIs will have higher HA-
CDI rates than study hospitals that have higher rates of CLABSIs. 
Hypothesis 2(b):  Study hospitals that have lower rates of CAUTIs will have higher HA-
CDI rates than study hospitals that have higher rates of CAUTIs. 
Mimetic pressures. 
Mimetic pressures exist when an organization will imitate the actions of similar 
organizations because they are within the same organizational field.  In the area of HAI 
prevention, it has been proposed that hospital participation in a surveillance system 
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which monitors and reports on HAIs in hospitals could result in reduced HAI rates 
(Gastmeier et al., 2006).  Hospitals can use benchmark data to effect practice changes.  
Benchmarking allows hospitals with higher rates of infections to compare themselves 
with hospitals with lower rates and to set goals to copy the practices of the hospitals that 
are “best practice.”  For example, a benchmarking study of the insertion and care of 
central venous catheters (CVCs) was conducted among academic medical center 
hospitals to compare hospitals’ adherence to recommended CVC insertion and 
maintenance practices as defined by a set of clinical and operational performance 
measures (Harting et al., 2008).  An organization that perceives a great amount of 
mimetic ismorphic pressure within an organizational field is likely to imitate the practices 
of other organizations that have successfully implemented CDI practices.  In 2011, there 
were 15 states that had implemented CDI Prevention Collaboratives.  The goals for CDI 
collaboratives are usually related to sharing and identifying best practices in the 
prevention of CDI among collaborative members in order to reduce the occurrence of 
HA-CDI.  There is some evidence that shows that hospitals that participated in CDI 
Prevention Collaboratives demonstrated reductions in their CDI rates (Koll et al., 2013). 
Thus, there is some data to suggest that hospitals located in states in which there is the 
presence of a multihospital collaborative will have lower rates of HA-CDI.   
Hypothesis 3:  Study hospitals that are located in states that have implemented CDI 
Prevention Collaboratives will have lower rates of HA-CDI than study hospitals located 
in states that did not implement CDI Prevention Collaboratives. 
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Normative pressures.  
A source of normative forces within a hospital that may impact the occurrence of 
HA-CDI includes those stemming from the nursing profession.  Nurses are an important 
factor in the delivery of high-quality care (Needleman & Hassmiller, 2009).  A review of 
the nursing factors that have been shown to be important as they relate to HAIs include 
the nurse-to-patient ratio, the ratio of ‘pool staff’ to permanent staff, and the skill mix of 
total nursing personnel (Stone, Clarke, Cimiotti, & Correa-de-Araujo, 2004). 
Associations have been found between patient-to-nurse ratios and urinary tract and 
surgical site infections, with higher rates of infections in hospitals in which nurses care 
for more patients.  Further, nurse burnout as determined by the Maslach Burnout 
Inventory-Human Services Survey found that nurse burnout was also associated with 
higher rates of urinary tract and surgical site infections (Cimiotti, Aiken, Sloane, & Wu, 
2012).   
The American Nurses Credentialing Center (ANCC) accredits organizations with 
a Magnet® status if they have a high level of quality nursing, including a high rate of 
nurse retention and a positive work environment that is supportive of high-quality 
nursing care (The American Nurses Credentialing Center (ANCC), 2013).  Aiken and 
colleagues showed that Magnet hospitals had lower rates of inpatient mortality and 
failure-to-rescue among surgical patients compared to non-Magnet hospitals (McHugh 
et al., 2012).  Better outcomes have also been displayed for very-low-birthweight babies 
hospitalized in Magnet hospitals compared to non-Magnet hospitals (Lake et al., 2012).  
It has also been shown that among Magnet hospitals, there is a higher rate of adoption 
of National Quality Forum (NQF) Safe Practices as compared to non-Magnet hospitals 
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(Jayawardhana, Welton, & Lindrooth, 2012).  Thus, it appears that hospitals with 
Magnet status--with the implicit devotion to high-quality nursing care--should have lower 
rates of HA-CDI.  Leading to the fourth hypothesis, 
Hypothesis 4:  Magnet-designated study hospitals will have lower rates of HA-CDI than 
non-Magnet-designated study hospitals. 
In relation to CDI another source of normative pressures stem from professional 
groups, such as the infectious diseases practitioners and organizations such as SHEA 
and IDSA.  The Infectious Diseases Society of America and SHEA have published a 
clinical CDI guideline regarding the diagnosis and treatment of CDI.  Included in the 
guideline are recommendations for improving the diagnosis and management of CDI in 
adult patients.  Also included in the guideline are recommended methods of infection 
control and environmental management of C. difficile (Cohen et al., 2010).  Further, 
members of the organization SHEA have published a series of guidelines regarding 
strategies for the prevention of CDI as part of its compendium of ‘best practices’ for the 
prevention of HAIs in the acute care setting (Dubberke et al., 2008).  The author 
composition of the two guidelines is comprised of a panel of experts in the 
epidemiology, diagnosis, prevention, and/or clinical management of CDI; the majority of 
these experts are on staff at academic health centers.  A very active involvement of 
these professionals at the local level could impact organizational goals regarding CDI 
reduction.  The role of an infection prevention ‘Champion’ has been shown to be a very 
important aspect of successful infection prevention efforts (Saint et al., 2010).  Saint and 
colleagues found that the utilization of engaging, well-respected champions was a 
strategy to deal with ‘active resistance’ among clinicians who were impeding the use of 
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recommended practices to prevent HAIs (Saint et al., 2009).  Further, Seto and 
colleagues showed that information that was transferred by opinion leaders was more 
effective in the implementation of a new guideline on urinary catheter care than other 
strategies (Seto, Ching, Chu, & Seto, 1991).  This leads to the next hypothesis to be 
tested: 
Hypothesis 5:  Study hospitals that have CDI experts who participated in SHEA/IDSA 
guideline development on staff will have lower rates of HA-CDI than study hospitals that 
do not have CDI experts who particpated in SHEA/IDSA guideline development on staff.  
Rationalized myths. 
Regarding the study question and the occurrence of HAIs, a preventable harm, 
there exist several hospital scoring, or ranking, systems that aim to provide patients 
information concerning a hospital’s quality and safety profile.  Scoring well on the 
ranking systems implies that a hospital has adopted processes attributed to better care 
and improved patient outcomes.  The Leapfrog Group has developed a Hospital Safety 
Score that uses publicly available national performance measures from the Leapfrog 
Group Hospital Survey, the Agency for Healthcare Research and Quality (AHRQ), the 
CDC, and CMS to provide a single composite patient safety score from 28 measures 
(represented in a letter grade:  A-F), representing a hospital’s overall safety 
performance in terms of keeping patients safe from preventable harm and medical 
errors (Austin et al., 2013).  A nine-member expert panel developed the composite 
scored from process/structural measures and outcome measures which are used by 
national measurement and reporting programs, which are weighted equally at 50%.   
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Similarly, the U.S. News & World Report provides an annual listing of the “Best 
Hospitals;” these rankings were developed to help patients ascertain which hospitals 
provide the best care for the most serious or complicated medical conditions.  Hospital 
data are examined across a broad spectrum of patient care in terms of survival rates 
and patient safety across a broad range of sixteen adult medical specialties.  For twelve 
of the specialties (Cancer; Cardiology & Heart Surgery; Diabetes & Endocrinology; Ear, 
Nose, & Throat; Gastroenterology; Geriatrics; Gynecology; Nephrology; Neurology & 
Neurosurgery; Orthopedics; Pulmonology; and Urology), the hospital ranking is based 
largely on data from organizations such as the American Hospital Association (AHA) 
and CMS.  For four of the specialty areas (Psychiatry; Rehabilitation; Rheumatology; 
Ophthalmology), the ranking is based solely on a reputational survey that is completed 
by physicians.  An index of hospital quality (IHQ) is generated that is based on three 
dimensions of healthcare, structure, process and outcomes.  Further, the U.S. News & 
World Report tabulates what is known as the Best Hospitals Honor Roll.  This is an 
additional classification that designates excellence across a range of specialties.  To 
qualify for the Honor Roll, a hospital needs to be ranked at least three standard 
deviations above the mean IHQ in at least six out of sixteen specialties.   
It could be theorized that hospitals that achieve Honor Roll status or that have a 
high Safety Score letter grade have adopted practices perceived to be institutional 
norms regarding patient safety and quality.  However, the internal hospital operations of 
these hospitals may not reflect the ranking or score in terms of quality or safety.  For 
both the Honor Roll and Safety Score designations, some components of the score are 
based on structural data obtained from survey data (e.g., Is the cancer center a National 
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Cancer Institute-designated center?; Is the epilepsy center a designated Level 4 Center 
by the National Association of Epilepsy Center?; Does the hospital have computerized 
Physician Order Entry).  Also, a component of the score is based on CMS process 
measures (e.g., Are antibiotics given within one hour of surgical incision?).  However, 
some structural or process indicators have not necessarily been associated with better 
patient outcomes.  Regarding the process measures for community-acquired 
pneumonia, for example, there are limited randomized data to support many of the 
guideline recommendations regarding the timing and choice of antibiotic, and the 
performance of blood culture obtainment (Metersky, 2008). The measures are often 
derived from practice guidelines developed by professional organizations. Thus, these 
performance measures are not necessarily based on high-quality evidence.   
Implementation of some process measures has caused unintended harmful 
consequences, including patient harm.  Indeed, implementation of a process measure 
concerning administration of an antibiotic within four hours of a pneumonia diagnosis 
was possibly associated with an increase in severe CDI in one medical center (Polgreen 
et al., 2007).  Further, a change in the CMS process measures to provide antibiotics 
within four hours instead of eight hours for a pneumonia diagnosis resulted in a 
decrease of 10% in the accuracy of the detection of pneumonia (Welker, Huston, & 
McCue, 2008).  Also, an increase in the false-negative blood culture rate has been 
associated with an increased hospital length of stay in patients with a diagnosis of 
pneumonia (Metersky, Ma, Bratzler, & Houck, 2004).  
Further, as described above, a component of the Honor Roll criteria is 
established by a reputational survey, which is conferred by an external group of 
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evaluators.  As such, a designation such as an Honor Roll hospital may not necessarily 
reflect on the internal processes in a hospital related to patient quality and safety.  For 
example, a high safety letter grade or Honor Roll designation would not necessarily 
reflect on the extent of implementation of a practice in a hospital (such as hand hygiene) 
and that patient outcomes, such as HA-CDI, would not necessarily be better in these 
hospitals.  That is, adoption of structural and process measures recognized as 
legitimate performance measures by such groups as Leapfrog Group and CMS may 
serve as rationalized myths.  The designation of an Honor Roll Hospital or a high safety 
grade confers legitimacy to the external environment, but may not necessarily reflect the 
quality and safety of the internal environment.  This leads to the last set of hypotheses: 
Hypothesis 6 (a):  HA-CDI rates will not vary by the study hospitals’  Leapfrog Group 
Hospital Safety Scores.™  
Hypothesis 6 (b):  Study hospitals that are ranked as a U.S. News & World Report Best 
Hospital Honor Roll member will not have HA-CDI rates that are different than non-
Honor Roll member hospitals.  
 In summary, in response to institutional pressures, organizations need to 
conform to these forces in order to acquire legitimacy and necessary resources, as well 
as a competitive advantage.  The more of these pressures present in the organization’s 
external environment, the more of an impact these factors should have on an 
organization’s decision to, for example, adopt or improve a necessary innovation, such 
as HA-CDI prevention practices.  From an instiutional theory perspecive, there are 
isomorphic pressures that organizations face when developing strategies in response to 
forces external to an organization.  Specifically, there are forces acting on hospitals that 
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may influence actions that hospitals take to decrease rates of HA-CDI.  Table 1 outlines 
the organizational forces that may impact rates of HA-CDI represented in the developed 
hypotheses and their direction of their predicted relationship to HA-CDI rates.  
 An overview of the instiutional theory perspective presented in this chapter 
provided a framework to generate study hypotheses related to the research question of 
which organizational factors impact on hospitals decisions to adopt measures to 
decrease HA-CDI.  The next chapter, chapter four, describes the study design and the 
analyses that will be used. 
Table 1  
Summary of Hypotheses and Expected Results 
Hypothesis Organizational Factor  Expected Result 
Coercive Forces   
1  State mandatory CDI reporting (-) States with mandatory reporting will have lower 
HA-CDI 
2 (a) CLABSI rates (-)  Higher CLABSI SIR hospitals will have lower HA-
CDI 
2 (b) CAUTI rates (-)  Higher CAUTI SIR hospitals will have lower HA-
CDI 
Mimetic Forces   
3 State-led CDI Prevention 
Collaborative 
(-)  States with prevention collaboratives will have 
lower HA-CDI 
Normative Forces   
4 Magnet hospital 
designation 
(-)  Magnet-designated hospitals will have lower HA-
CDI 
5 CDI physician experts  (-)  Hospitals with a CDI physician expert on staff will 
have lower HA-CDI 
Rationalized Myths   
6 (a) Leapfrog Group™ Safety Score No association between Safety Score and HA-CDI 
6 (b) U.S. News & World Report Best 
Hospital Honor Roll 
No association between being a  Best Hospital Honor 
Roll member and HA-CDI 
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Chapter 4:  Methodology 
 
Overview 
Using an institutional theory perspective and a hospital-level analysis, 
organizational factors will be tested with a multivariable negative binomial regression 
model to determine the relative contribution of each factor on rates of hospital HA-CDI.  
The HA-CDI rate will be risk-adjusted with hospital factors thought to be related to HA-
CDI occurrence in hospitals in order to make rates comparable across hospitals. 
Data Source 
Administrative claims data, including procedure- and diagnosis-specific data from 
discharge abstract summaries, were available from UHC members, an alliance of non-
profit academic health centers.  A subset of UHC hospitals subscribe to the Clinical 
Resource Manager (CRM) program.  The UHC CRM database is comprised of data 
regarding inpatient drug use.  The subset of non-specialty UHC hospitals (cancer 
hospitals such as M.D. Anderson and City of Hope were excluded) that participate in the 
UHC administrative database, including the CRM database, during calendar year 2011 
served as the data source.  Only data from adult patients ages 18 years or older were 
used.  Data from UHC have been used extensively in health services research 
investigations, including several that have been published in 2012 (Billeter et al., 2012; 
David, Medvedev, Hohmann, Ewigman, & Daum, 2012; Jalisi, Bearelly, Abdillahi, & 
Truong, 2013; Keroack et al., 2007; Utter et al., 2012). 
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Along with administrative data, the UHC database includes detailed information 
regarding every medication administered in the hospital setting for which charges were 
generated.  Patient-level use of antibiotics for systemic use are measured and 
aggregated to hospital-wide use.  Antibiotic use is measured in days of therapy (DOTs).  
The methodology of measuring antibiotic use as DOTs is the standard for antibiotic drug 
measurement established by the CDC’s NHSN (Centers for Disease Control and 
Prevention, 2012).  For example, if a patient received a single dose of an antibiotic drug 
on a given day, whether or not multiple doses are administered, it is registered as ‘1 
DOT.’  If a patient received more than one antibiotic drug on the same day, each 
antibiotic is counted as 1 DOT.  The UHC CRM drug database has been described in 
detail in previous investigations as well as its validation (Pakyz et al., 2008).  Cases of 
HA-CDI will be defined as patients with any (primary or secondary) ICD-9 CM diagnosis 
code for CDI (008.45) and the Present on Admission (POA) indicator equal to ‘No’, 
meaning no, not present at the time of the inpatient admission. 
Development of HA-CDI Risk-adjusted Dependent Variable 
Risk adjustment methodologies are established for some cardiac outcomes, 
(Krumholz et al., 2006a; Krumholz et al., 2006b) but as yet there is not yet an identified 
gold standard methodology for risk-adjustment of infection rates among hospitals.  As 
there is not a standard methodology, the risk-adjustment strategy employed is 
dependent on available data (Harris & McGregor, 2008).  The NHSN has established a 
methodology for calculating CLABSI Standardized Infection Ratios (SIRs) (The National 
Healthcare Safety Network., 2010).  An overall hospital CLABSI SIR compares the 
number of CLABSIs (or CAUTIs) in a hospital’s ICUs to a national benchmark based on 
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data reported to the CDC’s NHSN from 2006-2008, adjusted by type of ICU location.  
The hospital SIRs are compared to national sample of hospitals; the national baseline 
SIR is 1.0. A SIR value of less than 1.0 means that the hospital had fewer CLABSIs 
than were predicted, while a value of more than 1.0 indicates that the hospital had more 
CLABSIs than were predicted.  Thus, the CLABSI SIR provides a single risk-adjusted 
summary statistic that reflects several different ICU locations.  For the surgical site 
infection (SSI) SIR, the NHSN, for a given operative procedure, divides the number of 
observed infections by the number of expected infections (The National Healthcare 
Safety Network., 2010).  The number of expected infections is derived from a logistic 
regression model.  For example, for a particular NHSN operative procedure category, 
the factors that were included in the regression model were patient age, duration of 
procedure, and medical school affiliation status of the hospital.  The California 
Department of Public Health Center for Health Care Quality HAI Program suggests that 
CDI rates should be adjusted for patients who are 65 years of age or older, the rate of 
CDI community-onset (CO) cases, with these infections serving as a potential source for 
intra-hospital transmission, and severity of illness in the hospital patient population 
(California Department of Public Health, January 6, 2012.).  Members of the CDC’s 
NHSN presented at a scientific meeting in 2012 that the following hospital 
characteristics will be considered to determine risk-adjusted rates for the NHSN CDI 
reporting module:  hospital teaching type (major or other); bedsize; diagnostic test type 
(PCR, other); and CO CDI prevalence .  As the current study sample is comprised of  
academic health centers, there is no need to adjust for the characteristic teaching type 
in the current study. The characteristic bedsize will be considered as a risk-adjustment 
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factor in the model, while the CO CDI prevalence will be incorporated into the final 
model as a control variable. In addition, there are other factors that will be considered 
for the risk-adjusted models in the current study that are not available to the NHSN, but 
are available in the UHC CRM, and are predicted to relate to the number of HA-CDI 
cases in hospitals.  For risk-adjustment models, it is common to use stepwise 
procedures to build the models, meaning variables are either added or deleted to the 
model, a forward vs. a backward stepwise procedure, respectively, depending on the 
contribution of that variable on model fit (Lisa I. Iezzoni, 2012).  Forward stepwise 
variable selection is the most commonly used method and will be used in the current 
study (Harrell, 2001).  Specifically for the research study, a forward stepwise negative 
binomial regression technique will be used to select the most statistically important risk 
factors to predict HA-CDI occurrence.  That is, one variable will be added at a time, for 
each stage of model building, which contributes most to the model fit until a stopping 
point.  The stopping point will be based on the Akaike information criterion (AIC) value.  
Model building will begin with the two variables with the lowest p-values; the variables 
with the next lowest p-values will be added to the regression model one at a time; the 
model building process will stop once the AIC value increases.  The variable total 
antibiotic use will be forced into the model due its importance as a risk factor for HA-
CDI.  The risk-adjusted number of HA-CDI cases per hospital ascertained by the 
procedure described above was used in all the negative binomial regression models 
conducted to test the study hypotheses.   
There were a total of ten factors that were considered in the risk-adjustment 
negative binomial regression models.  The total number of hospital beds was included 
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as this variable has previously been found to be positively associated with HA-CDI 
(Labbe et al., 2008).   A geographic region variable was also added to the model, as the 
Northeast geographic region has been associated with higher rates of HA-CDI (Agency 
for Healthcare and Research and Quality, 2012).  Hospitals with a patient population 
that is more severely ill would be expected to have higher occurrence of HA-CDI; the 
California Department of Public Health has recommended that hospital case-mix index 
be considered in the adjustment of HA-CDI rates in California hospitals (California 
Department of Public Health, January 6, 2012.).  Thus, the hospital case-mix index 
(CMI) variable for discharges was included as a possible risk-adjustment factor.  The 
CMI variable represents the average diagnosis-related group (DRG) relative weight for 
a given hospital.   As longer lengths of hospital stay and older age is associated with the 
occurrence of HA-CDI (Bignardi, 1998; McDonald et al., 2006), the average hospital 
length of stay and the proportion of patients aged 65 years or older were also included 
as potential risk-adjustment factors.  Individual medication patient risk factors for HA-
CDI include medication use such as antibiotics, PPIs, and chemotherapeutic agents 
(Howell et al., 2010; McFarland et al., 1989; Owens et al., 2008; Stevens et al., 2011). 
Therefore the hospital-level use of these agents (expressed as days of therapy per 
1,000 patient days) was also included as potential risk-adjustment factors.  The CDI 
testing methodology type, either molecular testing (e.g. PCR) or non-molecular tests, 
was also included as a potential risk factor in the negative binomial risk-adjustment 
regression model, as the use of varying tests by laboratories to detect HA-CDI has 
resulted in differing HA-CDI rates among hospitals (Fong et al., 2011).  Finally, a lag 
variable representing a study hospital’s previous year (2010) rate of HA-CDI was 
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included in the HA-CDI risk-adjusted model.  Table 2 displays the predictors that will be 
entered into a multivariable regression model in order to obtain risk-adjusted hospital 
HA-CDI rates for each hospital, along with the expected impact of the factor on HA-CDI, 
and how the factor will be specified in the current study.   
Table 2   
Hospital-level Risk Factors Considered in Multivariable Risk-adjustment Regression  
Model 
Risk-adjustment Factor Predicted Impact on HA-
CDI Occurrence 
Factors Considered for 
Dependent Variable 
Construction 
Source 
Number of beds Larger bed sizes are 
associated with higher 
rates of HA-CDI (Dudeck 
M, Malpiedi P, Edwards J, 
MStat, Fridkin S, 
Mcdonald C, Sievert D. 
Centers for Disease 
Control and Prevention,  
(Labbe et al., 2008) 
Continuous 
 
UHC 
Region      The Northeast is 
associated with higher 
rates of HA-CDI (Agency 
for Healthcare and 
Research and Quality, 
2012) 
Four dichotomous 
variables that are coded 1 
to indicate the four main 
geographic regions of the 
census divisions  
Northeast:  CT, NJ, MA, 
NY, MD, PA, NH, RI, VT 
South:  AR, AL, DE, FL, 
MS, KS, LA, OK, GA, TN, 
TX, MO, NC, SC, VA, WV, 
Washington DC 
Midwest:  IL, IO, IN, KS, 
MI, MN,OH, MO, WI, NE, 
ND, SD 
West:  AZ, AL, AK, CO, A, 
ID, HI, OR, MT, NM, UT, 
WY, NV, WA 
Source:  UHC 
 
(Agency for 
Healthcare and 
Research and 
Quality, 2012) 
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Table 2 (continued) 
Risk-adjustment Factor Predicted Impact on HA-
CDI Occurrence 
Factors Considered for 
Dependent Variable 
Construction 
Source 
Case Mix Index (CMI)  Hospitals with a higher 
case mix index would be 
expected to have higher 
rates of HA-CDI indicating 
greater patient severity 
(California Department of 
Public Health, January 6, 
2012.) 
Continuous:  average 
Medicare CMI, usually 
averages around 1.0  
UHC 
Total Antibiotic 
Days of Therapy  
Antibiotics are associated 
with HA-CDI (Cohen et 
al., 2010; Owens et al., 
2008; Stevens et al., 
2011)  
Continuous:  
DOTs/1000PDs in year 
2011 
 
UHC 
Proton Pump Inhibitor 
Agents  
Gastric acid suppressant 
use is associated with 
HA-CDI (Howell et al., 
2010; Stevens et al., 
2011; U.S. Food & Drug 
Administration, 2011)                                                         
Continuous:  
DOTs/1000PDs in year 
2011 
 
UHC 
Chemotherapeutic agents  Chemotherapeutic agent 
use is associated with 
HA-CDI (McFarland et al., 
1989)  
Continuous:  
DOTs/1000PDs 
 
UHC 
Hospital Length of Stay 
(LOS) 
Longer LOS is associated 
with HA-CDI (Cohen et 
al., 2010) 
Continuous:  average LOS 
in 2011 
 
UHC 
Percentage of all inpatients 
≥ 65 years 
Older age is associated 
with HA-CDI (McDonald 
et al., 2006)  
Percentage: number of 
admissions with patients 
ages 65 or greater divided 
by total admissions in 
2011 
 
UHC 
CDI test methodology type Molecular testing is 
associated with higher 
HA-CDI rates than two-
step testing and toxin 
immunoassay (EIA) (Fong 
et al., 2011; Grein J, 
Ochner M, Jin A, Hoang 
H, Morgan M, Murthy R, 
2011). 
Categorical variable: 
testing methodology  
(1) molecular testing for 
whole year 2011 (2) 
molecular testing at least 
partial year or (3) other 
[two-step process (e.g. 
glutamate dehydrogenase 
(GDH) + cytotoxin or 
PCR) cytotoxin assay or 
EIA testing] 
    
Hospital 
Websites/ 
laboratory 
personnel at 
hospitals 
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Table 2 (continued) 
Risk-adjustment Factor Predicted Impact on HA-
CDI Occurrence 
Factors Considered for 
Dependent Variable 
Construction 
Source 
2010 HA-CDI   Represents lag variable:  
the hospitals previous 
year’s HA-CDI cases are 
likely to be related to the 
number the following year 
Continuous:  # of CDI 
ICD-9-CM codes in 2011 
for which POA equals 
‘No’, per 1,000 patient-
days. 
 
UHC 
Note:  The outcome variable will be the number of HA-CDI cases in 2011 (ICD-9 CM diagnosis code for 
CDI (008.45) and the Present on Admission (POA) indicator equal to ‘No’); the model will include an 
exposure function for the number of total patient days for each hospital in order to account for different 
number of patient days at each hospital (exposure rate).   
Development of HA-CDI Main Independent Variables  
In order to test each of the individual main hypotheses, eight separate 
multivariable regression models will be constructed to test the main independent 
variables with the risk-adjusted HA-CDI rate as the dependent variable.  These 
variables were previoulsy described in both chapter 2 and 3, in the sections related to 
risk factors for HA-CDI and in the discusssion of the proposed hypotheses.  Table 3 
displays a summary of the construct, the variable construction, and the data source for 
each main independent variable.  
Table 3   
Independent Variable Definitions, Construction, and Data Sources 
Main Independent 
Variables  
Construct Construction Source 
H1  State-required 
CDI public reporting 
State Regulatory 
Force 
Dichotomous variable, 
= 1 if hospital in a 
state that requires 
CDI reporting, 0 
otherwise 
CDC Morbidity and 
Mortality Weekly 
Report (MMWR) 
Publication 
(McDonald et al., 
2012) 
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Table 3 (continued) 
Main Independent 
Variables  
Construct Construction Source 
H2 (a)  CAUTIs  Federal (CMS) 
Regulatory Force 
Hospital CAUTI 
Standardized 
Infection Ratio (SIR): 
Value ranges around 
1.0. A SIR value of 
less than 1.0 means 
that the hospital had 
fewer CLABSIs than 
were predicted, while 
a value of more than 
1.0 indicates that the 
hospital had more 
CLABSIs than were 
predicted 
 
Hospital Compare 
Website (The Centers 
for Medicare & 
Medicaid Services, 
2013) 
 
 
 
Data reporting period: 
1/1/12-3/31/12 
H2(b) CLABSIs Federal (CMS) 
Regulatory Force 
Hospital CLABSI 
Standardized 
Infection Ratio (SIR): 
Value ranges around 
1.0. A SIR value of 
less than 1.0 means 
that the hospital had 
fewer CLABSIs than 
were predicted, while 
a value of more than 
1.0 indicates that the 
hospital had more 
CLABSIs than were 
predicted 
Hospital Compare 
Website (The Centers 
for Medicare & 
Medicaid Services, 
2013) 
 
 
 
 
Data reporting period: 
4/1/11-3/31/12 
H3  State-led CDI 
collaborative 
State Regulatory 
Force 
Dichotomous variable, 
= 1 if hospital in a 
state that 
implemented a CDI 
collaborative, 0 
otherwise 
 
CDC Website 
(Centers for Disease 
Control and 
Prevention, 2013)  
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Table 3 (continued) 
Main Independent 
Variables  
Construct Construction Source 
H4  Magnet 
designation 
Normative Force: 
Nursing Care  
Categorized as 0,1, 2; 
0 = not a Magnet 
hospital; 1= a Magnet 
hospital in year 2003 
or earlier; 2 = a 
Magnet hospital from 
year 2004-2011,in 
order to assess the 
impact of early vs. 
later adopter of 
Magnet designation 
vs. no adoption 
 
American Nurses 
Credentialing Center 
(ANCC) Website (The 
American Nurses 
Credentialing Center 
(ANCC), 2013) 
H5  CDI physician 
experts 
Normative Force: CDI 
Medical Experts 
Dichotomous variable, 
= to 1 if author of 
IDSA/SHEA or SHEA 
CDI guidelines, 0 
otherwise 
SHEA Guideline & 
SHEA/IDSA CDI 
Guidelines (Cohen et 
al., 2010; Dubberke et 
al., 2008) 
H6 (a) Leapfrog 
Group Patient Safety 
Score 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normative Force: 
Patient Safety  
Categorical variable: 
the Leapfrog Group’s 
Hospital Safety 
Score™ (‘A’, ‘B’, ‘C’, 
‘D’, ‘F’). [Some 
categories may be 
combined due to low 
number of 
observations in a 
category, such as the 
Grades of ‘D’ and ‘F’.]  
The Leapfrog Group’s 
Hospital Safety 
Score™ Website 
(grades for the 2 MD 
hospitals in the 
sample will be based 
on other best hospital 
scoring systems such 
as the U.S. News & 
World Report’s 
ranking.  If the 
hospital was a Best 
Hospital Honor Roll 
hospital, it will be 
given a grade of ‘A’, 
otherwise it will be 
given the average 
grade of all other 
hospitals).  
H6 (b) U.S. News & 
World Report Best 
Hospital Honor Roll 
Normative Force: 
Patient Safety 
Categorical , = to 1 if 
ranked a Honor Roll 
member for 2011-
2012, 0 otherwise 
Website (U.S. News & 
World Report, 2012)                                
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Development of HA-CDI Control Variables  
Several structural, market, and environmental control factors were included in all 
of the regression models.  Factors that were considered include the types of patients 
that a hospital serves (demographics, severity), or patient mix. To account for the 
patient mix of the hospital, several control variables were included. First, the proportion 
of patients in the hospital who had received care in an intensive care unit (ICU) was 
included in the regression models.  Increased patient serverity, such as ICU stay, has 
been associated as a risk factor for acquiring HA-CDI (Riddle & Dubberke, 2009).  The 
number of patients with a diagnosis of HIV, or who had undergone a gastrointestinal 
procedure, or a solid organ or bone marrow transplant, was also included as a control 
variable.  These patient comorbid conditions have also been associated with an 
increased risk of HA-CDI in hospitalized patients (Collini et al., 2012; Sanchez et al., 
2005; Thibault et al., 1991).  Further, the proportion of patients who had been admitted 
from either a long-term care facility or another hospital was also included as a control 
varible.  Patient admission from these admission source types has also been associated 
with an increased risk for HA-CDI (Jarvis et al., 2009).  Further, the number of patients 
with a diagnosis code for CDI with a POA indicator equal to ‘Y’ or ‘W’ or ‘U’, indicating 
that the patient was admitted with CDI, or, community-onset CDI (CO CDI) was also 
included as a control variable.  An increased admission prevalence of CDI has also 
been associated with an increased risk of a patient developing HA-CDI when 
hospitalized (Zilberberg et al., 2011) .  
Several variables were included in the model to account for hospital 
environmental factors that may impact on a hospital’s quality performance, and 
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therefore impact HA-CDI occurrence.  The hospital location, whether located in a 
metropolitan region or not, was considered as a control variable in the regression 
models for its potential impact on health outcomes.  For example, smaller hospitals 
located in rural areas have been shown to have an increase in 30-day mortality rates for 
acutue myocardial infarction, congestive heart failure, and pneumonia as opposed to 
hospitals located in urban regions which saw a decrease; mortality rates for the three 
conditions were found to be higher in hospitals located in rural areas (Joynt, Orav, & 
Jha, 2013).  The Disproportionate Share Hospital (DSH) patient percentage, which 
represents the sum of the percentage of Medicare inpatient days that are attributed to 
patients eligible for both Medicare Part A and Supplemental Security Income (SSI), and 
the percentage of total inpatient days that are attributed to patients eligible for Medicaid, 
but not Medicare Part A, was used as a measure of socioeconomic disadvantage 
(Centers for Medicare & Medicaid Services, 2013).  That is, if a hospital was in the 
upper quartile of the study sample of DSH patient percentages, it was considered a 
safety-net hospital (Ryan, Blustein, Doran, Michelow, & Casalino, 2012).  Hospitals that 
serve disadvantaged populations have been shown to perform less well on performance 
measures for acute myocardial infarction (Popescu, Werner, Vaughan-Sarrazin, & 
Cram, 2009).  Race was also considered as a socioeconomic factor.  Regarding quality 
outcomes, race has been found to be a determininat of LOS, mortality, and 
readmissions among patient s admitted for congestive heart failure (Philbin & DiSalvo, 
1998).  Race has also been associated with a decrease in the use of invasive 
procedures after acute myocaridal infarction (Philbin et al., 2000). There has also 
previously been shown an association between older black Medicare patients and 
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minority-serving hospitals and higher 30-day readmission rates for patients with 
congestive heart failure, pneumonia, and acute mycoardial infarction (Joynt, Orav, & 
Jha, 2011).   
Finally, the Herfindahl-Hirschman Index (HHI) was used to represent hospital 
competitive pressure.  The HHI was based on bed capacity.  Specifically, the squared 
sum of beds per metropolitan statistical area was calcuated for each hospital, which 
ranged from 0-1, with numbers closer to 0 signfiying a less concentrated marked, and 
numbers close to 1 signifying a greater market concentration of hospitals.  A value of 
1.0 would indicate only one hospital in the specified market.  Hospital competition may 
spur quality.  Indeed, regarding quality outcomes, the HHI effect has been negatively 
associated with pneumonia mortality rates among hospitals in different system types 
(Chukmaitov et al., 2009), implying that hospitals with located in markets with increased 
competition had better outcomes.  Increased competition has also been associated with 
a greater performance on quality indicators among nursing homes (Zinn, 1994).  Table 
4 displays a summary of the construct, the variable construction, and the data source 
for each control variable as described above.   
Table 4   
Control Variable Definitions, Construction, and Data Sources 
Independent Control 
Variables 
Construct Construction Source 
CO CDI CDI cases that are 
community-onset (not 
hospital-acquired) 
# of CDI ICD-9-CM 
cases for which POA 
= ‘Yes’, ‘U’ or ‘W’ in 
2011 by 1,000 patient 
days 
 
UHC 
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Table 4 (continued) 
Independent Control 
Variables 
Construct Construction Source 
Solid organ and bone 
marrow 
transplantation center, 
digestive system 
surgeries performed, 
and number of HIV-
infected patients 
Organizational 
structural feature:  
case mix (high risk 
medical complexity for 
CDI) 
Total # of solid organ 
and bone marrow 
transplant procedures 
(MS-DRG codes: 1, 2, 
5-9, 14-17) + total # of 
digestive system 
operations (MS-DRG 
codes:  326-358) + # 
of HIV cases (MS-
DRG codes: 969-977) 
by 1,000 patient days 
 
UHC 
ICD-9-CM Disease 
and Procedure Codes 
obtained from CDC 
Website  
(Centers for Disease 
Control and 
Prevention, 2011) 
Intensive Care Unit 
Days 
Organizational 
structural feature:  
case mix acuity 
Percentage:  # of ICU 
admissions in patients 
ages 65 or greater 
divided by total 
admissions for 
persons ages 18 or 
greater 
 
UHC 
Source of Admission:  
long-term care or 
hospital 
Organizational 
structural feature:  
case mix  
Percentage:  # of 
admissions in patients 
ages 65 or greater 
with admission source 
of long-term care or 
hospital divided by 
total admissions for 
persons ages 18 or 
greater 
 
UHC 
Herfindahl-Hirschman 
index (HHI) 
Environmental:  
competitive pressure 
Calculated by 
squared sum of beds/ 
total beds per 
metropolitan statistical 
area; ranges between 
0-1 (Phibbs & 
Robinson, 1993) 
 
AHA 
Race/ethnicity Environmental: 
socioeconomic mix of 
patient population 
Proportion of patients 
that are Black and 
Other (non-Caucasian 
and non-Black) 
 
UHC 
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Table 4 (continued) 
Independent Control 
Variables 
Construct Construction Source 
Hospital location Environmental: 
patient mix of 
population 
Dichotomous variable, 
= to 1 if hospital 
located in a 
metropolitan region, 0 
otherwise 
 
AHA 
Safety-net  Hospital Environmental:  
socioeconomic patient 
mix of population 
Dichotomous variable, 
= to 1 if hospital in top 
quarter of Medicare 
Disproportionate 
Share index 
[Medicare 
Supplemental 
Security (SSI) days ÷ 
total Medicare days] + 
Medicaid days among 
non-Medicare patients 
÷ total patient days], 0 
otherwise 
Medicare Hospital 
Cost Report 
Note:  POA classifications: 
Y = Yes, present at the time of inpatient admission 
U = Unknown, documentation  is insufficient to determine if the condition is present on admission 
W = Clinically undetermined, provider is unable to clinically determine if the condition is present on 
admission or not.   
Empirical Model 
The following empirical model was tested (the model included patient days as an offset):  
Hospital Risk-Adjusted HA-CDI cases = exp (Intercept + B1*Hypothesis + B2*CO 
CDI + B3*SOT/BMT/HIV/Surgery + B4*ICU + B5*Source + B6*HHI + B7*Race-
Black + B8*Race-Other + B9*Location + B10*Safety-Net)    
Where hospital risk-adjusted HA-CDI rate is the dependent variable, the risk-
adjusted number of hospital cases of HA-CDI; where hypothesis is one of eight 
independent variables, either whether the hospital is located in a state with mandatory 
CDI reporting (dummy variable 0/1), or whether the hospital is located in a state with a 
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state-led CDI prevention collaborative (dummy variable 0/1), or the CAUTI SIR 
(continuous variable), or the CLABSI SIR (continuous variable), or the Leapfrog Group 
Patient Safety Score (dummy variable 1/2/3), or whether the hospital is a U.S. News & 
World Report Best Hospital Honor Roll member (dummy variable 0/1), or whether the 
hospital is designated as a Magnet hospital (dummy variable 0/1), or whether there is a 
CDI physician expert on staff at the hospital (dummy variable 0/1); where CO CDI 
represents the CDI cases that are community-onset (continuous variable); where 
SOT/BMT/HIV/Surgery represents the number of patients with either a solid or bone 
marrow organ transplant, gastrointestinal surgery, or with an HIV diagnosis (continuous 
variable); where ICU represents the hospital percentage of patients with ICU 
admissions; where source represents the proportion of patient admissions with an 
admission source of either long-term care facility or hospital; where HHI represents the 
Herfindahl-Hirschman index (continuous variable); where Race-Black represents the 
proportion of patients that  are Black; where Race-Other represents the proportion of 
patients that are a race other than black or Caucasian, non-Hispanic; where location 
represents whether the hospital is located in a metropolitan area (dummy variable 0/1); 
and where Safety-net represents whether a hospital is in the top quartile of the DSH 
patient percentage (dummy variable 0/1).   
Analytic Approach 
Descriptive analyses of all the main independent and control variables were 
conducted, including calculation of the mean, standard deviation, median, and range for 
continuous variables.  Bivariate analyses were conducted to assess the relationship 
between the independent variables and the dependent variable.  
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Eight multivariable negative binomial regression models were conducted to test 
the individual hypotheses concerning organizational risk factors associated with higher 
HA-CDI rates.  Negative binomial regression binomial models were chosen as they are 
used when the dependent variable is a count of events (Woolridge, 2009).  Poisson 
regression techniques are also appropriate for count data when the variance of the 
dependent variable equals its mean.  A dispersion test will be conducted, if the results 
are not significant, meaning that the variance does not exceed the mean, then Poisson 
regression techniques will be used.  For all regression models, robust standard errors 
were applied as defined by the statistical software package (such as the Huber/White 
heteroscedastic consistent estimator of the variance/covariance matrix in Stata) to 
produce valid standard error estimates and t-statistic values in the presence of 
heteroscedasticity and correlation.  Variance Inflation Factors (VIF) were generated by 
running least squares regression models with all the variables to assess for collinearity.  
Model diagnostics were not conducted to assess residual normality or variable linearity 
since a negative binomial regression model was utilized; independent variables are not 
expected to be linearly related to the dependent variable.  Since negative binomial 
regression models were used to conduct the analyses, in order to assess goodness of 
fit of the models, Information Criteria statistics were used, such as the Akaike’s 
Information Criteria (AIC).  The AIC of the empty model containing the intercept was 
compared to the explanatory models.  Stata version 12 (StataCorp LP) was used for all 
analyses; a two-sided significance value of < 0.05 was considered significant.   
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Sensitivity Analyses 
Additional analyses were conducted in order to evaluate the robustness of the 
results.  The regression models were re-run using a different definition for HA-CDI.  The 
new definition included not only the CDI ICD-9-CM code with POA = ‘No’ to define HA-
CDI, but also including POA = ‘U’, unknown, and POA = ‘W’, clinicaly undetermined, to 
assess the impact of potentially differing coding practices across hospitals on study 
results.  Further, additional analyses were conducted to assess the robustness of the 
laboratory testing methodology classification; the variable was re-classified per the 
following:  (1) molecular (e.g. PCR) for whole year 2011; (2) molecular at least partial 
year or two-step process (e.g. glutamate dehydrogenase (GDH) + cytotoxin or PCR) or 
cytotoxin assay; (3) EIA testing.  
In summary, this chapter reviewed the methodology of the current research 
including the data source, the study sample, study design, construction of main 
independent variables of interest and control variables, and the analytic approach.  In 
short, eight separate multivariable negative binomial regression models will be 
conducted in order to test the generated hypotheses concerning whether institutional 
pressures are associated with the occurrence of CDI in hospitals.  Chapter five provides 
the results of these analyses.  
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Chapter 5:  Results 
  
 The results of the analyses are presented in this chapter.  Descriptive statistics 
are provided for the model variables, as well as the results of the bivariate and final 
negative binomial regression model analyses that assess the forces that influence risk-
adjusted HA-CDI.  Further, the results of the sensitivity analyses are presented in this 
chapter. 
Sample 
Of the 98 UHC CRM members, a total of 89 (91%) were represented in the study 
sample.  Three hospitals were eliminated from the study sample as they were cancer 
specialty hospitals (2) or a correctional facility hospital (1). The remainder six hospitals 
were removed from the sample because of incomplete or unreliable drug data for year 
2011.  Specifically, either drug data were not reported for all four quarters for a hospital 
in year 2011(4), or the data were not accurate due to implementation of a new 
electronic medical record system in the hospital (2).  
Descriptive Statistics 
 Table 5 displays the descriptive statistics for the potential risk-adjustment 
variables.  The average hospital bedsize was 623, and the median was 553, indicating 
that the study sample was comprised of mainly larger sized hospitals; the average CMI 
among hospitals was 1.92, well over 1.0, indicating the severity and complexity of 
patients hospitalized in academic health centers.  Antibiotics were used more commonly  
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Table 5   
Characteristics of Potential Risk-adjustment Factors 
Risk-adjustment Factor Mean (standard deviation);  Range 
Number of beds 623 (255); 204 - 1,280 (median = 553) 
Region, No (%)       
      Northeast 25 (28%) 
      South 27 (30%) 
      Midwest 20 (23%) 
      West 17 (19%) 
Case Mix Index (CMI)  1.92 (0.228); 1.35-2.54 
Total Antibacterial 
Days of Therapy / 1000 patient-
days 
 
518 (77); 236-686 
Total Proton Pump Inhibitor (PPI) 
Days of Therapy / 1000 patient-
days 
440 (121); 92-745 
Total chemotherapeutic agents 
Days of Therapy / 1000 patient-
days 
 
14 (9.5); 1.43-56 
Average hospital Length of Stay 
(LOS) 
6.03 (0.765); 4.57-8.0 
Percentage of all inpatients ≥ 65 
years 
 
34 (10); 11-57 
CDI test methodology type No. 
(%) 
 
 
 
Molecular (e.g. PCR) testing for 
whole 2011  
 
32 (36%) 
Molecular testing at least partial 
year 
 
20 (22%) 
Other:  two-step process (e.g. 
glutamate dehydrogenase (GDH) 
+ cytotoxin assay or PCR) or 
cytotoxin assay test or EIA testing 
 
37 (42%) 
2010 HA-CDI  (# of 2010 POA = 
‘N’ cases/1,000 patient days) 
0.724 (0.295); 0.121-1.39 
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than PPIs; chemotherapeutic agents were used less frequently, with the average 
hospital total DOTs/1,000PDs equal to 518, 440, and 14, respectively.  On average, 
among hospitals, 34% of all inpatients were aged 65 or greater.  The majority of 
hospitals, 58%, used PCR the whole year in 2011, or at least partial year for the CDI 
testing methodology.  Before risk-adjustment of HA-CDI cases, the average number of 
HA-CDI cases highly varied; the average number of cases was 57.1 (standard deviation 
= 45.0), range 3-239. 
Table 6 displays the descriptive statistics for the main independent variables 
Regarding the main independent variables of interest, nearly one-half of hospitals were 
located in a state where there was a state-led CDI collaborative.  Approximately one-
quarter of hospitals (26%) were located in a state with mandatory CDI reporting.  The 
average SIR for CAUTIs was higher than for CLABSIs, 1.28 vs. 0.059, respectively.  
The most common Leapfrog Group Patient Safety Grade was C (44%), followed by an 
A (35%), and then B (17%).  Three hospitals had a grade of D, while one hospital had a 
grade of F.  Sixteen percent of the hospitals were a U.S. News & World Report Best 
Hospital Honor Roll member and sixteen percent of hospitals had a CDI guideline 
member on staff.  Forty-five percent of hospitals did not have a Magnet designation, 
while 25% received a Magnet designation in year 2003 or prior, and 30% received a 
Magnet designation in year 2003-2011.     
 Regarding the control variable characteristics, the average percent of admissions 
in patients aged 65 or greater to ICUs was 19%, while the average percent of 
admissions among patients aged 65 or greater with an admission source of long-term 
care or another hospital was 14%.  The average Herfindahl index was 0.143, reflecting  
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Table 6   
Characteristics of Main Independent Variables 
Main Independent 
Variables  
Mean (standard deviation); Range 
Hospitals located in 
states with mandatory 
CDI reporting in year 
2011 or before, No. 
(%) 
 
23 (26%) 
Hospitals located in 
state that 
implemented a CDI 
collaborative, No. (%) 
 
43 (48%) 
Hospital CAUTI 
Standardized 
Infection Ratio (SIR) 
 
1.28 (1.03); 0-7.32 
Hospital CLABSI 
Standardized 
Infection Ratio (SIR) 
 
0.059 (0.32); 0.023-1.89 
Leapfrog Group 
Patient Safety Score, 
No. (%) 
 
 
     ‘A’; ‘B’; ‘C’;‘D’;’F’ 
 
31 (35%); 15 (17%); 39 (44%); 3 (3%); 1 (1%) 
U.S. News & World 
Report Best Hospital 
Honor Roll, No. (%) 
 
14 (16%) 
Magnet designation  
None; year 2003 or 
earlier; year 2004-
2011, No. (%) 
 
40 (45%); 22 (25%); 27 (30%) 
Number of hospitals 
with CDI guideline 
member on staff, No. 
(%) 
14 (16%) 
Note:  Based on variable distribution, variable categorized into ‘A’ = referent, ‘B’ = 1, ‘C’, ‘D’ & ‘F’ = 2.  
One of the two Maryland hospitals was classified as an ‘A’ as it was a U.S. News & World Report Best 
Hospital Honor Roll member, the other was classified as a ‘C’, which was the most common grade among 
the study sample. 
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that hospitals were generally located in competitive markers, while the average DSH 
patient percentage was 40%, but ranged from 6.0%-95%. This indicated a wide range 
by individual hospital in the proportion of patients whose payer was either Medicare or 
Medicaid, representing differences among hospitals in the amount of care provided for 
poorer patients. The average percent of admissions was 20% and 17% among Black 
patients and Other race patients, respectively. The average rate of CO-CDI among 
hospitals was 1.67, while the average rate of solid organ and bone marrow 
transplant/HIV/gastrointestinal surgery cases was 5.95.  All but one hospital was located 
in a metropolitan region; this variable was not included in the final analyses due to lack 
of variability in its distribution among hospitals.  These results are displayed in Table 7.     
 
Table 7   
Characteristics of Control Variables 
Independent Control Variables Mean (standard deviation); Range 
CO CDI:  # of CDI ICD-9-CM 
cases for which POA = ‘Yes, U 
and W’* in 2011 per 1,000 patient 
days 
 
1.67 (0.729); 0.390-4.24 
Total # of solid organ and bone 
marrow transplant procedures 
(MS-DRG codes: 1, 2, 5-9, 14-17) 
+ total # of digestive system 
operations (MS-DRG codes:  
326-358) + # of HIV cases (MS-
DRG codes:  969-977) per 1,000 
patient days 
 
5.95 (1.60); 3.22-10.5 
Percentage:  # of ICU admissions 
in patients ages 65 or greater 
divided by total admissions for 
persons ages 18 or greater 
 
19 (7.6); 4.6-55 
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Table 7 (continued) 
Independent Control Variables Mean (standard deviation); Range 
Percentage:  # of admissions in 
patients ages 65 or greater with 
admission source of long-term 
care or hospital divided by total 
admissions for persons ages 18 
or greater 
 
14 (7.0); 0.038-33 
Herfindahl index: Calculated by 
squared sum of beds/ total beds 
per metropolitan statistical area; 
ranges between 0-1 
 
0.143 (0.190); 0.01-1.0 
Race/ethnicity:  percentage  
          Other 17 (15); 1.0-84 
          Black 
 
20 (16); 0.068-86 
DSH patient percentage 
 
40 (18); 6.0-95 
Hospital Location. No. (%)*   
          Metropolitan Region 88 (99%) 
          Other 1 (1.0%) 
*Note:  The variable hospital location was not used in negative binomial models due to lack of variability  
Results of Risk-adjustment Analyses 
 The variables specified for risk-adjustment analyses were entered in a 
multivariable negative binomial regression model to ascertain associations with the 
number of HA-CDI cases.  The variables with the smallest p-values in ascending order 
were:   HA-CDI rate 2010 (P = 0.000); proportion of patients > 65 years of age (P = 
0.000); testing methodology (P = 0.012); total antibiotics (P =  0.099); average LOS (P = 
0.137); chemotherapy agents (P = 0.166); region (P = 0.332); GAS agents (P = 0.432); 
bedsize (P = 0.657); and CMI (P = 0.670).  In order to ascertain the number of risk-
adjusted HA-CDI cases for hospitals, the two variables with the smallest p-values were 
first entered into a negative regression binomial model to obtain the AIC value; 
subsequently the next variable entered into the model was the variable with the next 
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smallest p-value until the AIC value started to increase.  The variable total antibiotic was 
forced in the model due to its importance as a risk factor for HA-CDI.  The final risk-
adjustment model included the following five variables:  HA-CDI rate 2010; proportion of 
patients > 65 years of age; total antibiotics [AIC = 713.6] ; testing methodology [AIC = 
712.4] ; and average length of stay [AIC = 712.0].  The risk adjusted HA-CDI number of 
cases ranged from 6.8 to 238 (mean = 57; median = 43) across hospitals.   
The following represents the final risk-adjustment model:  
HA-CDI cases = Exp (Intercept + B1*HA-CDI rate 2010 + B2*Prop-65 +  
B3*LOS + B4*Testing methodology + B5*Antibiotics)   
Where HA-CDI rate 2011 is the dependent variable, the number of hospital cases 
of HA-CDI; where HA-CDI rate 2010 is the lag variable, representing the number of 
hospital cases of HA-CDI in 2010 (continuous variable; the number of cases with a 
diagnosis code for CDI equal to ‘Y’ or ‘W’ or ‘U’ per 1,000 patient days); where Prop-65 
is the proportion of hospital patients aged 65 or greater; where LOS is the average 
hospital LOS; where testing methodology was whether molecular tests were used 
whole, or partial year, or not used (dummy variable 1/2/3); and where antibiotics is the 
total antibiotic drug use per hospital in year 2011 (continuous variable; DOTs/1,000 
patient days).  
Table 8 displays the results of the bivariate analyses of the main independent 
variables of interest and risk-adjusted HA-CDI.  The bivariate analyses showed that 
three of the main independent variables of interest were significantly associated with 
HA-CDI:  CLABSIs; U.S. News & World Report Honor Roll hospital; and Magnet 
designation in year 2006 or before (as compared to non-Magnet hospital).  The direction 
of association was negative as predicted for CLABSIs, while the direction of association 
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was positive for U.S. News & World Report Honor Roll hospitals, which was predicted to 
be non-significant.  Also, the direction of association was the opposite as predicted for a 
Magnet designated hospital in year 2006 or before (as compared to non-Magnet 
hospitals), which was positive, but predicted to be negative.     
Table 8   
Results of Bivariate Associations Between Main Independent Variables and Dependent 
Variable 
Main 
Independent 
Variables  
 Estimate 
(β) 
(standard 
error)    
Z P-value 95% CI 
State CDI 
reporting  
 
0.1670921 
(0.1010) 
1.65 0.098 -0.0309287    0.3651128 
CDI 
collaborative 
 
0.0647483 
(0.0989) 
0.65 0.513 -0.1292745    0.2587711 
CAUTI 
Standardized 
Infection Ratio 
(SIR) 
 
-0.019877 
(0.0465) 
-0.43 0.669 -0.1110797    0.0713257 
CLABSI 
Standardized 
Infection Ratio 
(SIR) 
 
-0.303368 
(0.1493) 
-2.03 0.042* -0.5959332   -0.0108027 
Leapfrog Group 
Patient Safety 
Score (‘A’ = 
referent) 
 
    
    ‘B’ -0.1876632 
(0.1487) 
-1.26 0.207 -0.4791674     0.103841 
    ‘C’, ‘D’, or ‘F’ -0.080461 
(0.1047)   
-0.77 0.442 -0.2857347    0.1248127 
U.S. News & 
World Report 
Best Hospital 
Honor Roll 
 
0.1820901 
(0.0886)  
2.06 0.040* 0.0084907    0.3556894 
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Table 8 (continued) 
Main 
Independent 
Variables  
 Estimate 
(β) 
(standard 
error)    
Z P-value 95% CI 
Magnet 
designation (not 
a Magnet 
hospital = 
referent) 
 
    
Magnet 
designation in 
year 2003 or 
prior 
 
0.3278988 
(0.11638) 
2.82 0.005* 0.0997824    0.5560151 
Magnet 
designation 
years 2004-
2011 
 
0.1388881 
(0.1150) 
1.21 0.227 -0.0864899    0.3642661 
CDI guideline 
member  
-0.0114591 
(0.1293) 
 
 
-0.09 0.929 -0.2650657    0.2421475 
*significant at P < 0.05 
 
Testing the Hypotheses:  Negative Binomial Regression Results 
Results of the dispersion test (P < 0.01) indicated that binomial regression 
techniques were more appropriate for the count data than Poisson regression, an 
indication that the variance exceeded the mean for the outcome variable distribution.   
The VIFs revealed that there were no issues with collinearity among the variables in the 
negative binomial regression models.  The average VIFs for the eight models were 
1.36, 1.38, 1.40, 1.40, 1.40, 1.41, 1.41, and 1.48.  No individual variable VIF value 
exceeded 1.74 in any of the models.  All of the explanatory models had lower AIC 
values than the empty model containing only the intercept, indicating that the models 
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with explanatory variables had predictive ability greater than the model with no 
explanatory variables.  The AIC for the empty model was 807.1; the AIC values for the 
eight negative binomial regression models were 734.9, 745.5, 745.6, 745.7, 745.9, 
744.2, 746.8, and 745.6 for U.S. News Best Hospital Honor Roll member, CDI physician 
expert, CAUTIs, CLABSIs, Magnet designation, state CDI public reporting, Leapfrog 
Group Patient Safety Grade, and state-led CDI Prevention Collaborative models, 
respectively.   
H1: State-required CDI public reporting.  
 The results of the model testing whether hospitals located in states where there 
was mandatory HA-CDI reporting showed that the mandatory CDI reporting variable 
was not significant (P = 0.169), and that that direction of the coefficient was opposite as 
predicted.  That is, the coefficient was positive, while it was predicted that hospitals in 
states with mandatory HA-CDI reporting would have lower rates of HA-CDI.  There were 
three control variables that were significant including:  CO CDI (P = 0.000); HHI (P = 
0.021); and Safety-net (P = 0.000).  For CO CDI, the coefficient was positive and for 
HHI and Safety-net, it was negative. 
H2 (a):  Central line-associated bloodstream infections (CLABSIs). 
 For the model with CLABSIs as the main independent variable, the CLABSI 
variable was not significant (P = 0.737); the coefficient was negative as predicted.  
Control variables that were significant include HHI (P = 0.012), CO CDI (P = 0.000),   
and Safety-net (P = 0.000); the HHI coefficient and Safety-net coefficients were 
negative, while the CO CDI coefficient was positive. 
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H2 (b):  Catheter-associated urinary tract infections (CAUTIs). 
 The results of the model with CAUTIs as the main independent variable showed 
that this variable was not significant (P = 0.685) and the coefficient was positive vs. 
negative as predicted.  The control variable CO CDI was significant and positive (P = 
0.000).  The control variable coefficients HHI and Safety-net were significant and 
negative, (P = 0.009) and (P = 0.000), respectively.   
H3:  State-led collaborative. 
 For the model testing whether hospitals located in states where there was a 
state-led HA-CDI prevention collaborative had lower occurrence of HA-CDI, the results 
indicated that this variable was not significantly associated with HA-CDI (P = 0.663); the 
direction of the coefficient was negative, as predicted.  The control variable CO CDI was 
significant and positive (P = 0.000).  The control variables HHI and Safety- net were 
significant and negative, (P = 0.011) and (P = 0.000), respectively.   
H4:  Magnet-designated hospital. 
 The results of the model with Magnet-designated hospital as the main 
independent variable showed that this variable was not significant (P = 0.208) for 
Magnet designation, prior to year 2004, or for Magnet designation from 2004-2011 (P = 
0.942), as compared to no Magnet designation.  The coefficients were positive vs. 
negative as predicted.  There were three control variables that were significant 
including:  CO CDI (P = 0.000); HHI (P = 0.015); and Safety-net (P = 0.001).  For CO 
CDI, the coefficient was positive, while for HHI and Safety-net, the coefficients were 
negative. 
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H5: Clostridium difficile physician expert. 
For the model testing whether hospitals that had a CDI expert on staff had lower 
HA-CDI, the results indicated that having an expert on staff was not significantly 
associated with HA-CDI (P = 0.562); the coefficient was negative as predicted.  The 
control variable CO CDI was significant and positive (P = 0.000).  The control variables 
HHI and Safety-net were significant and negative, (P = 0.008) and (P = 0.000), 
respectively.   
H6 (a): Leapfrog group hospital safety score. 
 The results of the model with the Leapfrog Group Safety Score as the main 
independent variable showed that this variable was not significant  for a safety score 
equal to “B” (P = 0.314), or for a safety score equal to “C, D, or F” (P = 0.586), as 
compared to a safety score of “A.”  It was predicted that there would be no association 
between a hospital’s safety score and HA-CDI.  There were three control variables that 
were significant including:  CO CDI (P = 0.0008); HHI (P = 0.011); and Safety-net (P = 
0.001).  For CO CDI, the coefficient was positive, while for HHI and Safety-net, the 
coefficients were negative. 
H6 (b):  U.S. News & World Report best hospital honor roll. 
 The results of the model testing whether Best Hospital Honor Roll designation 
was associated with HA-CDI showed that being an Honor Roll hospital was significant 
and positively associated with HA-CDI (P = 0.000).  It was predicted that there would be 
no association between Honor Roll designation and HA-CDI.  There were five control 
variables that were significant including:  CO CDI (P = 0.000); HHI (P = 0.016); Safety-
net (P = 0.001); the number of solid and bone marrow organ transplants, 
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gastrointestinal surgeries and HIV diagnoses (P = 0.042); and other race (P = 0.041).  
For CO CDI, the coefficient was positively significant, while for the other four variables it 
was negative.   
Tables 9-16 show the coefficient, standard errors, the z-value and p-values, as 
well as the 95% Confidence Intervals (CI) for the independent and control variables for 
the eight negative binomial regressions conducted to test the study hypotheses.   
Table 9   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  State Mandatory CDI Reporting 
 
Variable 
Coefficient (β) 
(Standard error) 
z p-value 95% CI 
Mandatory CDI 
reporting 
0.1024047 
(0.0745273) 
 
1.37 0.169   -0.043666    0.2484755 
CO CDI    0.3663505 
(0.0548395) 
 
6.68 0.000*   0.258867     0.473834 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0201965 
(0.0215682) 
-0.94 0.349 -0.0624694    0.0220765 
ICU admissions  0.0005042 
(0.0053795) 
0.09 0.925 -0.0100395    0.0110479 
Admissions with 
source of long-
term care or 
hospital  
 
0.8163196 
(0.5170657) 
1.58 0.114   -0.1971105     1.82975 
Herfindahl index -0.3840308 
(0.166279) 
 
-2.31 0.021* -.07099328   -0.0581287 
Race:  other -0.0037164 
(0.0026358) 
 
-1.41 0.159 -0.0088825    0.0014497 
Race:  black -0.0028602 
(0.0021504) 
 
-1.33 0.183 -0.0070748    0.0013544 
Safety-net  -0.3056553 
(0.0798875) 
-3.83 0.000* -0.4622318   -0.1490788 
*significant at P < 0.05 
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Table 10   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  CLABSIs 
Variable Coefficient (β) 
(Standard 
error) 
z p-value 95% CI 
CLABSI -0.0422447   
(0.1258) 
 
-0.34 0.737 -0.2887624    0.2042729 
CO CDI  0.3687994 
(0.05630 
 
6.55 0.000* 0.2583777    0.4792211 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0183833  
(0.02148) 
-0.96 0.392 -0.060494    0.0237273 
ICU admissions  -0.0000319  
(0.0054) 
 
-0.01 0.995 -0.0106774    0.0106137 
Admissions 
with source of 
long-term care 
or hospital  
 
0.8476775  
(0.5266) 
1.61 0.107 -0.1844991    1.879854 
Herfindahl 
index 
-0.4224874 
(0.1677) 
 
-2.52 0.012* -0.7512152   -0.0937595 
Race:  other -0.0027429 
(0.0026) 
 
-1.04 0.297   -0.0079004    0.0024145 
Race:  black -0.0030784 
(0.0021) 
 
-1.46 0.144 -0.0072116    0.0010548 
Safety-net  -0.3049218 
(0.0834) 
-3.65 0.000* -0.4684556   -0.1413879 
*significant at P < 0.05 
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Table 11   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  CAUTIs 
Variable Coefficient (β) 
(Standard 
error) 
z p-value 95% CI 
CAUTI 0.0171014 
(0.0422) 
 
0.40 0.685 -0.0656613    0.0998641 
CO CDI  0.3698435 
(0.0568) 
 
6.51 0.000* 0.258484     0.481203 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.017613 
(0.0209) 
-0.84 0.401 -0.0587379     0.023512 
ICU admissions    -0.0004652   
(0.0053) 
 
-0.09 0.931 -0.0109339    0.0100034 
Admissions 
with source of 
long-term care 
or hospital  
0.8136177 
(0.5323) 
1.53 0.126 -0.2297651       1.857 
Herfindahl 
index 
-0.4242856   
(0.1634) 
 
-2.60 0.009*   -0.7446171   -0.1039541 
Race:  other   -0.0028563   
(0.0025) 
 
-1.10 0.270 -0.0079276    0.0022151 
Race:  black -0.0031424  
(0.0021) 
 
-1.46 0.144 -0.0073541    0.0010694 
Safety-net    -0.3143923  
(0.0823) 
-3.82 0.000* -0.4758547     -0.15293 
*significant at P < 0.05 
 
 
 
  78 
Table 12   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  State-led CDI Prevention Collaborative 
 
Variable 
Coefficient (β) 
(Standard 
error) 
Z p-value 95% CI 
CDI 
collaborative 
-0.029163 
(0.0668327) 
 
0.44 0.663 -0.1018261    
0.1601532 
CO CDI  0.3709888 
(0.0568732) 
 
6.52 0.000* 0.2595194    
0.4824583 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0192562 
(0.0215411) 
-0.89 0.371 -0.061476    
0.0229637 
ICU admissions  .0001847 
(0.0053627) 
 
0.03 0.973 -0.010326    
0.0106953 
Admissions with 
source of long-
term care or 
hospital  
 
0.8354038 
(0.526968) 
1.59 0.113 -0.1974356    
1.868243 
Herfindahl index -0.4139172 
(0.1625813) 
-2.55 0.011* -0.7325708   -
0.0952637 
Race:  other -0.0029468 
(0.0026159) 
 
-1.13 0.260 -0.0080738    
0.0021803 
Race:  black -0.0028878 
(0.0021761) 
 
-1.33 0.184 -0.0071529    
0.0013773 
Safety-net  -0.310611 
(0.833008) 
-3.73 0.000* -0.4738775   -
0.1473445 
*significant at P < 0.05 
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Table 13   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:   Magnet status 
Variable Coefficient (β) 
(Standard error) 
z p-value 95% CI 
Magnet status 
(Referent = no 
Magnet status) 
1:  Magnet 
status, 2003 or 
prior 
2:  Magnet 
status, 2004-
2011 
 
 
 
 
0.1098461  
(0.0872) 
 
0.0063016 
(0.0868) 
 
 
 
 
1.26 
 
 
0.07 
 
 
 
0.208 
 
 
0.942 
 
 
 
-0.0611117    0.2808039 
 
 
-0.1639555    0.1765588 
CO CDI  0.3622099 
(0.0576) 
 
6.28 0.000* 0.2491964    0.4752234 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0194318 
(0.0203) 
-0.96 0.388 -0.0592157    0.0203522 
ICU admissions  0.0001597 
(0.0055) 
 
0.03 0.977 -0.0106142    0.0109336 
Admissions 
with source of 
long-term care 
or hospital  
 
0.8443038 
(0.5032) 
1.68 0.093 -0.1419358    1.830543 
Herfindahl 
index 
-0.4041426 
(0.1667) 
 
-2.42 0.015* -0.730922   -0.0773632 
Race:  other -0.0023227 
(0.0027) 
 
-0.84 0.403 -0.0077701    0.0031247 
Race:  black -0.0025981 
(0.0021) 
 
-1.23 0.220 -0.0067515    0.0015554 
Safety-net  -0.2999 
 (0.0899) 
-3.33 0.001* -0.4762468   -0.1236483 
*significant at P < 0.05 
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Table 14   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  CDI Physician Expert 
Variable Coefficient (β) 
(Standard error) 
Z p-value 95% CI 
CDI physician 
expert 
-0.0570609 
(0.0983) 
 
-0.58 0.562 -0.2498156    0.1356939 
CO CDI  0.3671686 
(0.0560) 
 
6.55 0.000* 0.2572378    0.4770994 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0159  
(0.0217) 
-0.73 0.463 -0.0585156    0.0266447 
ICU admissions  -0.0003 
 (0.0054) 
 
-0.06 0.955 -0.0110169    0.0103957 
Admissions 
with source of 
long-term care 
or hospital  
 
0.8014497 
(0.5258) 
1.52 0.128   -0.2292789    1.832178 
Herfindahl 
index 
-0.426737  
(0.1601) 
 
-2.66 0.008* -0.7406126   -0.1128613 
Race:  other -0.002733 
(0.0025) 
 
-1.06 0.290 -0.0077991    0.0023331 
Race:  black -0.0027828 
(0.0021) 
 
-1.28 0.202 -0.0070604    0.0014947 
Safety-net  -0.3274162 
(0.0864) 
-3.79 0.000* -0.4967106   -0.1581218 
*significant at P < 0.05 
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Table 15   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  Leapfrog Group Hospital Safety Grade 
Variable Coefficient (β) 
(Standard 
error) 
z p-value 95% CI 
Leapfrog Group 
(referent = A) 
2: B 
 
3:  C, D, or F 
 
 
-0.0964683  
(0.0958) 
 
-0.0410463 
(0.07543) 
 
 
-1.01 
 
 
-0.54 
 
 
0.314 
 
 
0.586 
  
 
-0.2842419    0.0913052 
 
 
-0.1888955     0.106803 
CO CDI  0.367344  
(0.0553) 
 
6.65 0.0008* 0.2590177    0.4756703 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0185125 
(0.0210) 
-0.88 0.379 -0.0597862    0.0227612 
ICU admissions  -0.0000693 
(0.00550) 
 
-0.01 0.990 -.0107833    .0106447 
Admissions 
with source of 
long-term care 
or hospital  
 
0.8139796 
(0.5094) 
1.60 0.110 -0.1844484    1.812408 
Herfindahl 
index 
-0.418355 
(0.1654) 
 
-2.53 0.011* -0.7426025   -0.0941074 
Race:  other -0.0029594 
(0.0026) 
 
-1.14 0.255 -0.0080565    0.0021378 
Race:  black -0.003056  
(0.0021) 
 
-1.44 0.151 -0.0072225    0.0011105 
Safety-net  -0.3013834 
(0.0886) 
-3.40 0.001* -0.4750306   -0.1277361 
*significant at P < 0.05 
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Table 16   
Results of Multivariable Regression Associations Between Main Independent Variables 
and Dependent Variable:  U.S. News Best Hospital Honor Roll 
Variable Coefficient (β) 
(Standard 
error) 
z p-value 95% CI 
U.S. News Best 
Hospital Honor 
Roll 
 
0.2965953 
(0.0755) 
3.92 0.000* 0.1484623    0.4447284 
CO CDI  0.3969  
(0.0566) 
7.00 0.000* 0.2858746    0.5080881 
Solid organ and 
bone marrow 
transplants/HIV/ 
GI surgery  
 
-0.0389145  
(0.0191) 
-2.03 0.042* -0.0764023   -0.0014266 
ICU admissions  0.0018839  
(0.0052) 
 
0.36 0.717 -0.008315    0.0120828 
Admissions 
with source of 
long-term care 
or hospital  
 
0.7347096 
(0.4343) 
1.69 0.091 -0.1164802    1.585899 
Herfindahl 
index 
-0.3759739 
(0.1562) 
 
-2.41 0.016* -0.6822263   -0.0697215 
Race:  other -0.0050439  
(0.0024) 
 
-2.04 0.041* -0.0098845   -0.0002033 
Race:  black -0.0032509 
(0.0022) 
 
-1.46 0.145 -0.007622    0.0011203 
Safety-net  -0.2580862 
(0.0786) 
-3.28 0.001* -0.4121763   -0.1039961 
*significant at P < 0.05 
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Results of Sensitivity Analyses 
For the results of the sensitivity analyses whereby the testing methodology was 
categorized per the following: (1) molecular (e.g. PCR) for whole year 2011; (2) 
molecular at least partial year or two-step process (e.g. glutamate dehydrogenase 
(GDH) + cytotoxin or PCR) or cytotoxin assay; and (3) EIA testing, the results were 
similar for all the negative binomial regression models as to the primary set of analyses.  
The variable U.S. News & World Report Honor Roll member remained significant and 
positively associated with risk-adjusted HA-CDI [coefficient = 0.2811417, standard error 
= 0.080427, z = 3.50, p-value= 0.000, and 95% CI = 0.1235076 -0.4387757].   
 For the results of the sensitivity analyses whereby the definiton of HA-CDI cases 
included not only the CDI ICD-9-CM code with POA = ‘No’ to define HA-CDI, but also 
including POA = ‘U’, unknown, POA = ‘W’, clinically undetermined, to assess the impact 
of potentially differing coding practices across hospitals on study results, the results 
were also similar to the primary analyses.  The variable U.S. News & World Report 
Honor Roll member remained significant and positively associated with risk-adjusted 
HA-CDI.  [coefficient = 0.1143165, standard error = 0.048409, z = 2.36, p-value = 0.018, 
and 95% CI = 0.0194348 -0.2091983].  For both of the sensitivity analyses, there were 
no other significant findings among the main variables of interest, similar to the primary 
set of analyses.   
   This chapter presented descriptive statistics for all study variables, and the 
results of the bivariate and negative binomial regression model analyses.  Further, the 
results of the sensitivity analyses were also presented.  The next chapter will interpret 
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and discuss the results.  The future research direction stemming from these analyses 
will also be discussed. 
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Chapter 6:  Discussion and Conclusions 
 
 
Clostridium difficile infection is an HAI that is associated with great morbidity 
among hospitalized patients; since the early 2000s, CDI has been increasing in severity 
and incidence due to an epidemic strain.  The purpose of this research was to ascertain 
the types of organizational factors that are associated with HA-CDI occurrence using an 
institutional theory perspective to derive hypotheses.  This chapter summarizes and 
interprets the study results, and also discusses the study implications. 
Summary and Interpretation of Analysis Results 
 The descriptive analyses revealed that the study sample was comprised of large 
academic health centers, with the median number of beds being 553.  Hospitals were 
located relatively evenly throughout the four geographic census regions of the United 
States.  These analyses also revealed that the study sample of hospitals provided 
complex medical care with the average CMI being 1.92 among hospitals, and the 
average LOS equal to 6.03 days.  Over one-half of the hospitals were using state-of-the 
-art technology for CDI detection, such as the molecular-based tests, for the entire study 
year, or at least for the partial study year, an indication of a trend towards a switch to 
the molecular-based tests from less sensitive CDI testing methods, such as the EIA 
methodology.    
Regarding HA-CDI, there was a wide range of HA-CDI occurrence among 
hospitals, with the average number of HA-CDI risk-adjusted cases being 57, with a 
range from 7-238 cases.  Among the factors that were considered in the risk-adjustment 
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analyses, the number of 2010 HA-CDI cases, the proportion of patients greater than 65 
years of age, the testing methodology utilized, the hospital average length of stay, and 
total antibiotics were included in the final risk-adjustment models.  The hospital 
geographic region, the hospital number of beds, the CMI, and the total hospital days of 
therapy of chemotherapeutic and gastric acid suppressant agents were not included in 
the risk-adjusted HA-CDI model.   
The bivariate analyses showed that three of the eight main independent variables 
of interest were significantly associated with HA-CDI:  CLABSIs; U.S. News & World 
Report Best Hospital Honor Roll hospital; and Magnet designation in year 2006 or 
before (as compared to non-Magnet hospital).  The CLABSI variable was negative as 
predicted, meaning that hospitals that had a higher CLABSI SIR (meaning higher rates 
of CLABSIs), had lower HA-CDI.  It was theorized that if hospitals had higher rates of 
CLABSIs, that this would be associated with lower rates of HA-CDI, since hospitals with 
higher CLABSI rates may not have been focusing only on CMS-monitored infections.  It 
was also theorized that hospitals that were designated as a U.S. News & World Report 
Best Hospital Honor Roll hospital would have rates of HA-CDI that were no different 
than hospitals that were not an Honor Roll member.  Instead, on bivariate analysis, it 
was found that being an Honor Roll hospital was associated with more HA-CDI 
occurrence, as opposed to a non-Honor Roll hospital.  It was also theorized that 
hospitals with Magnet status would have lower occurrence of HA-CDI; however, it was 
found that hospitals that had received Magnet status in year 2003, or prior, had higher 
rates of HA-CDI.  The Leapfrog Group Patient Safety Score was not found to be 
significantly associated with HA-CDI, as predicted.  It was theorized in this case that 
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hospitals that had a higher safety score, such as a letter grade of ‘A’, would have HA-
CDI occurrence among hospitalized patients no different than hospitals that had a lower 
safety letter grade, such as a ‘B’, or lower.      
These analyses imply that at least two of the hypotheses would potentially be 
supported by the multivariable models (CLABSIs and Leapfrog Group Safety Score).  
However, the only hypothesis supported by the current research upon conduction of the 
multivariable negative binomial regression models was the hypothesis stating that there 
would be no significant association between the Leapfrog Group Safety Score and HA-
CDI.  Indeed, hospitals with a safety score of either ‘B’ or ‘C’, ‘D’, or ‘F’, had rates of HA-
CDI that were no different than hospitals with a safety score of ‘A.’  There was one 
significant finding among the eight models for the main independent variables, which 
was for the model testing U.S. News & World Report Honor Roll Hospitals and HA-CDI.  
The relationship predicted here was that there would be no difference in HA-CDI 
occurrence between Honor Roll hospitals and non-Honor Roll hospitals, but the 
relationship was found to be significant and positive, similar to the bivariate analyses.  
This indicated that being an Honor Roll member hospital was associated with higher 
rates of HA-CDI, as compared to non-Honor Roll hospitals.   
Other independent control variables that were found to be significantly 
associated with the outcome variable were the rate of CDI cases that were community-
onset (CO CDI), the HHI, and the hospital Safety-net variable.  The CO CDI rate was 
positively associated with risk-adjusted HA-CDI, while the HHI and Safety-net variables 
were negatively associated with HA-CDI.  While the direction of the coefficient for CO 
CDI was as predicted, meaning that a higher prevalence of CO CDI in the hospital was 
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associated with higher HA-CDI occurrence, the directions of the other coefficients were 
unexpected findings.  That is, it was predicted based on previous literature, that 
decreased hospital competition would be associated with increased rates of HA-CDI.  
What the regression analyses revealed, however, was that with an increase in hospital 
competition, there was decreased HA-CDI occurrence.  Further, it was predicted that 
Safety-net hospitals, as defined by the top quartile of the DSH patient percentage, 
would have a positive relationship to HA-CDI.  That is, hospitals caring for a greater 
proportion of poorer patients would have higher rates of HA-CDI.  Instead, a negative 
relationship was found in all of the regression analyses, indicating that being a Safety-
net hospital, as defined in the current proposal, was associated with less HA-CDI 
occurrence.  The control variable ‘other’ race was significant and negatively associated 
with risk-adjusted HA-CDI in the U.S. News & World Report Best Hospital Honor Roll 
member model, also indicating that patient socioeconomic status may be associated 
with HA-CDI.  The rate of patients with diagnoses codes for HIV and bone marrow and 
solid organ transplants, as well as gastrointestinal surgeries was also significant in the 
U.S. News & World Report model; the relationship was negative (opposite of predicted).  
The remaining control variables were not significant in any of the models:  the 
proportion of patients that were black; the proportion of patients with an ICU stay; and 
the proportion of patients admitted from another hospital or long-term care facility.   
In summary, the multivariable analyses showed that one study hypothesis was 
supported (Leapfrog Group Patient Safety Score), and that another hypothesis had a 
positive significant finding by multivariable regression analyses results (U.S. News & 
Report Best Hospital Honor Roll); however the association was predicted to be non-
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significant.  Table 17 displays a summary of the negative binomial regression model 
expected and final results, followed by a section describing study findings in more detail 
regarding each study hypothesis.   
Table 17   
Summary Table of Final Hypotheses Testing Results 
Hypothesis Organizational Factor  Expected Result Final Result 
Coercive Forces    
1  State mandatory CDI 
reporting 
(-) States with 
mandatory reporting 
will have lower HA-CDI 
(+) 
2 (a) CLABSI rates (-)  Higher CLABSI SIR 
hospitals will have 
lower HA-CDI 
(-) 
2 (b) CAUTI rates (-)  Higher CAUTI SIR 
hospitals will have 
lower HA-CDI 
(+) 
Mimetic Forces    
3 State-led CDI 
Prevention 
Collaborative 
(-)  States with 
prevention 
collaboratives will have 
lower HA-CDI 
(-) 
Normative Forces    
4 Magnet hospital 
designation 
(-)  Magnet-designated 
hospitals will have 
lower HA-CDI 
(+) 
5 CDI physician experts  (-)  Hospitals with a 
CDI physician expert 
on staff will have lower 
HA-CDI 
(-) 
Rationalized Myths    
6 (a) Leapfrog Group™ 
Safety Score 
No association 
between Safety Score 
and HA-CDI 
No association 
6 (b) U.S. News & World 
Report Best Hospital 
Honor Roll 
No association 
between being a Best 
Hospital Honor Roll 
member and HA-CDI 
(+)* 
*significant at P < 0.05 
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H1: State-required CDI public reporting.  
It was hypothesized that hospitals located in states with mandatory CDI reporting 
would have lower rates of HA-CDI.  While the coefficient for this variable was not 
significant, it was positive.  Indeed, the average number of CDI cases was higher in 
hospitals located in states with CDI mandatory reporting as opposed to hospitals 
located in states that did not have mandatory CDI reporting, 64.9 (standard deviation = 
9.3) vs. 54.5 (standard deviation = 5.2), respectively.    
 An increased rate of HA-CDI in those hospitals located in states with mandatory 
CDI reporting may be due to increased detection of HA-CDI in those hospitals, or due to 
the increased surveillance taking place in these hospitals.  Another investigation has 
shown that the number of adverse drug events reported after implementation of a 
system to track errors resulted in a forty-fold increase in event reporting (Classen, 
Pestotnik, Evans, & Burke, 1992).  Alternatively, it is a possibility that mandatory 
reporting of HAIs does not result in decreased HAI rates.  An investigation that 
examined the effect of mandatory CLABSI reporting in states found that the reporting 
laws had no impact on CLABSI occurrence (Pakyz & Edmond, 2013).  However, in 
Ontario, Canada, it was found that after mandatory monthly public reporting of CDI was 
implemented, that the occurrence of CDI decreased by 26% across Ontario hospitals 
(Daneman et al., 2012).  The authors of the Canadian study attributed the decreased 
rate in CDI to a possible increased attention by hospitals to adhere to best practices for 
CDI prevention.  More research is needed regarding the impact of mandatory public 
reporting of HAIs.  Further, the impact of CMS’s reporting of CDI on the Hospital 
Compare Website, commencing in 2014, and of the future addition of CDI as one of the 
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performance measures considered in Value Based Purchasing, will need to be 
assessed.   
H2 (a & b):  Central line-associated bloodstream infections (CLABSIs) & 
catheter-associated urinary tract infections (CAUTIs). 
 It was hypothesized that due to CMS’ policy of no-payment for the extra costs 
associated with CLABSI or CAUTI development in hospitals that hospitals would be 
focused on the prevention of these two types of HAIs vs. CDI, which is not on the no-
payment list.  It was found that neither of these variable coefficients was significant, 
though the coefficient for CLABSIs was negative as predicted.  That is, increased 
CLABSI occurrence, as reflected by the CLABSI SIR, was associated with less HA-
CDIs.   
It is possible that a lack of significance for this variable indicates that hospitals, 
while they may target certain HAIs that are monitored by CMS, that this may not come 
at the expense of infection prevention efforts for other infection types.  However, it has 
been demonstrated that the CMS no-payment policy for CLABSIs had no impact on 
CLABSI rates in hospitals (Lee et al., 2012).  Further, an alternate explanation for the 
study finding is that hospitals are anticipating the upcoming CDI focus by CMS and the 
VBP program and have started to target CDI specifically, in addition to other CMS-
monitored infections.   
H3:  State-led CDI prevention collaborative. 
 It was hypothesized that hospitals located in states with a state-led CDI 
Prevention Collaborative would have less HA-CDI occurrence.  Despite the success of a 
CDI prevention collaborative being documented (Koll et al., 2013), this variable 
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coefficient was not significant, though was negative as predicted.  As there was another 
state variable considered in the study analyses, state mandatory reporting of HA-CDI, 
an additional negative binomial regression model was conducted to account for both 
state variables in the model. The results were the same as the individual regression 
models with the two state variables, that is state-led CDI Prevention Collaborative and 
CDI mandatory reporting coefficients were not significant, (P = 0.513 and 0.098, 
respectively) in the combined model.  These results indicate that there may be 
competing CDI infection prevention efforts ongoing at the local or regional level that 
were not captured in the current study.   
H4:  Magnet-designated hospital. 
 It was theorized that hospitals that had a Magnet designation would have lower 
occurrence of HA-CDI.   A Magnet designation would confer that the hospital provides a 
gold standard of nursing care quality.  However, in the current study, hospitals that had 
Magnet Status did not have HA-CDI rates any different as compared to non-Magnet 
hospitals (P = 0.208 for Magnet status in year 2003 or prior and (P =0.942) for Magnet 
designation in years 2004-2011); the direction of the coefficients was positive, the 
opposite as predicted.    
 There are three goals and guiding principles of the Magnet recognition program: 
to promote quality in a setting that supports professional practice; identify excellence in 
the delivery of nursing services to patients; and to disseminate best practices in nursing 
services.  The current Magnet recognition process focuses on structure and processes 
as opposed to outcomes.  An assumption of the recognition process is that good 
outcomes will follow appropriate structures and processes (The American Nurses 
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Credentialing Center (ANCC), 2013).  Though previous studies have shown better 
outcomes in Magnet hospitals as compared to non-Magnet hospitals (Lake et al., 2012) 
and higher adoption of National Quality Forum safe practices (Jayawardhana et al., 
2012; McHugh et al., 2012) , the current study showed that there was no association 
between Magnet status and HA-CDI.  It is possible that while Magnet designation may 
correlate with some aspects of hospital quality, that Magnet status may not necessarily 
confer better outcomes in the area of HAIs.  It is possible, too, that Magnet designation 
may serve in some regards as a ‘rationalized myth.’ That is, it is perceived that with 
Magnet status, a hospital provides better quality care, but in actuality, the care among 
Magnet hospitals is no different than non-Magnet hospitals.  More research is needed in 
this area to gain a better understanding of the impact of a Magnet status designation on 
various aspects of hospital quality measures, including HAIs.  
H5: Clostridium difficile physician expert. 
 It was hypothesized that hospitals that had a CDI physician expert on staff, as 
defined by a member of the SHEA/IDSA CDI guideline, would have lower rates of HA-
CDI, with the assumption that they would serve in the role of a Physician Champion who 
would lead efforts in CDI prevention.  Previously, it has been demonstrated that  
Physician Champions were instrumental in improving the quality of antibiotic prescribing 
for acute respiratory tract infections (Aagaard et al., 2010)   However, in the current 
study, this hypothesis was not supported; this variable coefficient was in the direction as 
predicted, negative, but was not significant (P =0.562).   
 The fact that the coefficient was not significant in this case does not necessarily 
mean that Physician Champions are not important in the area of HA-CDI prevention.  It 
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could be that the guideline members did not serve in the role of a Physician Champion, 
or that there were physicians serving in this role in study hospitals who were not 
members of the SHEA/IDSA guideline committee.  Further, it is possible that other 
professional groups serve as Champions in this area, such as nurses.  Nurses have 
served as clinical champions in the area of influenza immunization (Mouzoon et al., 
2010) and in the implementation of central venous catheter infection prevention bundles 
(Lemaster, Hoffart, Chafe, Benzer, & Schuur, 2013). 
H6 (a): Leapfrog group hospital safety score. 
It was hypothesized that hospitals with a higher Leapfrog Group Hospital Safety 
Score would have HA-CDI rates that were no different than hospitals with a lower Safety 
Score.  Indeed, it was found that there were no significant differences among hospitals 
with a grade equal to ‘B’ or ‘C’, ‘D’, or ‘F’ as compared to hospitals with a letter grade 
equal to ‘A.’  The Leapfrog Group Hospital Safety Score is based on 26 measures 
established by a panel of nine national expert members.  A total of fifteen of these 
measures are either process or structural measures which are weighted at 50% of the 
composite score, while a total of eleven are outcomes measures, which are also 
weighted at 50%.  The single composite score is meant to represent a single score to 
enable an overall view of a hospital’s performance in the area of safety (Austin et al., 
2013).     
As this study hypothesis was supported by the results, it suggests that when 
hospitals adopt certain structural elements or comply with certain process measures, 
that this does not necessarily translate into all areas of hospital safety.  Though one of 
the process measures was specifically related to the prevention of HAIs, hand hygiene, 
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many of the measures were not necessarily related to infection prevention.  One of 
eleven outcome measures was related to another HAI, CLABSI occurrence; however, 
the vast majority of the outcome parameters used in the composite score were 
unrelated to HAI occurrence.   
H6 (b):  U.S. News & World Report best hospital honor roll. 
 Using an institutional theory perspective, it was predicted that the U.S. News & 
World Report Best Hospital Honor Roll members would have rates of HA-CDI that were 
no different than non-Honor Roll hospitals.  The results were not as predicted.  That is, 
the Best Hospital Honor Roll members had significantly higher rates of risk-adjusted 
HA-CDI as compared to non-Honor Roll hospitals.   
In examining the criteria for an Honor Roll hospital designation, it is not 
immediately apparent as to why Honor Roll hospital membership would be associated 
with higher rates of HA-CDI.  For twelve of sixteen specialty rankings, the generated 
index of hospital quality (IHQ) ranking is based on hard data (various secondary data 
sources), while for four of the sixteen specialties, the rankings are based on reputational 
surveys that are completed by physicians for the Best Hospital scoring system.  The 
IHQ score is based on structure, process, and outcome criteria.  
The scoring system uses data from the AHA Annual Survey Database, and CMS 
and other professional groups, such as the National Association of Epilepsy Centers, to 
acquire data concerning structural measures related to quality of care across 1,879 
hospitals.  The structural measures included certain key technologies and types of 
advanced care that would be provided from a “Best hospital.”  For example, information 
concerning diagnostic radioisotope services, procedures that lead to ablation of 
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Barrett’s esophagus, and endoscopic ultrasound procedures, among many other 
technology types, were considered.  There were a total of fifteen technologies that were 
considered important in one or more specialty areas.  There is also a volume index as 
part of the structural score, which takes into consideration the number of certain medical 
and surgical discharge types within specialty-specific MS-DRG groupings that were 
submitted to CMS for reimbursement.  Other components of the structure process care 
include information regarding nursing staffing, trauma center designation, patient 
services such as language translation, and intensivist staffing.    
Regarding the outcomes portion of the score, 30-day risk-adjusted mortality rates 
based on certain moderate intensity, or greater Medicare Severity Diagnosis Related 
Groups (MS-DRG) were used.  The mortality rate was adjusted according to observed 
and expected mortality rates using the 3M Health Information System’s MS grouper 
software, which uses the All Patient Refined DRG patient severity measures.  Hospitals 
that had a higher than expected mortality rate were considered to have lower-than-
average quality, and vice versa.       
Regarding the process portion of the IHQ score, a proxy measure was used due 
to the difficulty in obtaining national data on process measures.  This was based on the 
reputational scores from the past three Best Hospital rankings in 2009, 2010, and 2011.  
Specifically, a total of 200 physicians were asked to list up to five hospitals that were the 
“Best hospitals” in their specialty area for serious or difficult conditions, regardless of 
location or expense.  It was thought that physician endorsement of a designated “Best 
hospital” served as a proxy to represent the healthcare processes, such as physicians’ 
decision-making, choices about admission, treatment and medications, and length of 
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stay.  For four of the specialty ranking areas (Ophthalmology, Psychiatry, Rehabilitation, 
Rheumatology), only the reputation score as described above is used to establish the 
Best Hospital ranking score, as structural and outcomes measures were not considered 
pertinent to these specialties. 
Finally, a patient safety index component was also included as part of the IHQ.  
For this, information concerning the Agency for Healthcare Research and Quality 
(AHRQ) Patient Safety Indicators (PSIs) was considered.  A total of six of the fifteen 
PSIs were chosen for inclusion in calculation of the patient safety index.  These 
included:  death among surgical patients with serious treatable complications; iatrogenic 
pneumothorax; postoperative hemorrhage or hematoma; postoperative respiratory 
failure; postoperative wound dehiscence; and accidental puncture or laceration.  The 
PSI component comprised 5.0% of the total specialty IHQ score, while outcome and 
process components comprised 32.5% each, and structure comprised a total of 30%.  
The Honor Roll designation is meant to represent overall excellence, and is a 
method to establish relative distances between the 140 different hospitals that were 
ranked in at least one specialty.  To be an Honor Roll hospital, a hospital had to have 
been ranked at least three standard deviations above the mean in at least six out of the 
sixteen specialty areas.    
Similar to the Leapfrog Group Patient Safety Score, the Best Hospital Ranking 
Methodology does not incorporate many specific measures related to infection 
prevention.  Though Honor Roll hospitals are thought to offer excellent care for complex 
and severely ill patients, this designation may not necessarily translate into safer care in 
the form of HAI occurrence.  Despite the risk-adjustment techniques used in the Best 
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Hospital Methodology and the current study, it is possible that the study finding that 
Honor Roll hospitals had more HA-CDI may indicate that this group of hospitals 
provided the most complex care for the sickest of patients.  Thus, their higher rates of 
HA-CDI may be reflective of patient mix that was not completely accounted for by risk-
adjustment techniques.   
Study Robustness 
 The results of the two sensitivity analyses suggest that the results of the primary 
study analyses were robust.   The sensitivity analyses examined the robustness of the 
study results in regards to the methodology used to define HA-CDI cases and also the 
categorization of diagnostic testing for CDI.  Specifically, there were no differences 
found among the study results when CDI ICD-9-CM code information was used that 
include POA = ‘No’ as well as POA= ‘No’ plus POA = ‘U’, unknown, plus POA = ‘W’, 
clinically undetermined vs. POA = ‘No’ alone to define HA-CDI cases.  The study results 
were also not different upon categorizing the CDI testing methodology as (1) molecular 
(e.g. PCR) for whole year 2011; (2) molecular at least partial year or a two-step process 
(e.g. glutamate dehydrogenase (GDH) + cytotoxin or PCR) or cytotoxin assay; (3) or 
EIA testing, vs. categorized as either (1) molecular testing for whole year 2011, (2) 
molecular testing at least partial year or (3), or other [two-step process (e.g. glutamate 
dehydrogenase (GDH) + cytotoxin or PCR) cytotoxin assay or EIA testing].   
Study Implications 
 Of the eight hypotheses proposed, a total of one was supported by the study 
results.  That is, there was no difference in HA-CDI occurrence among hospitals with a 
Leapfrog Group Safety Score of ‘A’ vs. ‘B’, or ‘A’ vs. a grade of ‘C’, ‘D’, or ‘F.’  Further, 
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while it was predicted that Honor Roll hospitals would have no difference in HA-CDI 
occurrence, it was found that Honor Roll hospitals had higher-CDI occurrence.  While 
these analyses are exploratory in nature, and the findings could be spurious, or even 
that study power was low, there are several implications to the study findings.   
First, though the Leapfrog Group composite safety score is meant to provide 
patients and providers with a single score for hospital comparison in regards to safety 
performance, it does have some limitations.  For one, as demonstrated in the current 
study, the score does not necessarily represent all areas of patient safety, such as 
HAIs.  Second the structural, process, and outcome measures utilized in the score 
methodology may not be serving as appropriate indicators of patient safety.  Further 
studies are needed to determine the utility of various hospital scoring systems in terms 
of safety outcomes and to ascertain whether the goal in providing these types of data to 
providers and patients serves the purpose in the identification of safer hospitals and in 
spurring quality improvement.  
There may be other implications to the current study findings despite the fact that 
the majority of the hypotheses were not supported.  For example, there were a few 
interesting trends that were noted.  The rate of HA-CDI occurrence was higher in 
hospitals that were located in states with mandatory HA-CDI reporting, while accounting 
for several control variables and conducting risk-adjustment methodologies for HA-CDI 
rates.  This finding, in particular, has potential implications related to policy-making.  
Though it is not clear whether state policies related to HAI reporting result in less 
infections, it may be that initially after policy introduction, that the rate of infection 
reporting may increase, resulting in an increased number of infections.  This may be 
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especially true if there are infection validation procedures in place in hospitals (Oh et al., 
2012).   Regarding other state-led initiatives, in those states that had implemented a 
CDI Prevention Collaborative, it was found that there was no difference in HA-CDI 
occurrence as compared to hospitals located in states without a state-led collaborative.  
While state-led Prevention Collaboratives have been shown to be successful in 
reducing CDI, the voluntary nature of these programs may impact on their effectiveness.  
More research is needed to discern the impact in CDI rate reduction among different 
state policies directed towards reducing CDI.    
Regarding the finding concerning no differences in HAI occurrence among 
hospitals with a Magnet designation and those without, the coefficients were positive.  
As the number of hospitals that seek Magnet adoption increases (Abraham, Jerome-
D'Emilia, & Begun, 2013), the current study suggests that it is important that evaluations 
continue to study whether Magnet status implicates better patient outcomes and indeed 
serves as a gold standard in nursing quality.  For pursuit of a Magnet designation, 
hospital resources are needed to accommodate the required structures and processes 
that need to be in place.  If a Magnet designation does not necessarily warrant superior 
nursing care and result in better patient outcomes, these resources could be used to 
implement other quality program types that have been demonstrated to improve patient 
outcomes.    
There is a study finding directly related to clinical practice.  For one, the 
prevalence of CO CDI is important to consider when assessing risk for HA-CDI in 
hospitalized patients.  A higher prevalence of CO CDI was consistently associated with 
higher HA-CDI occurrence.  Further, there are study implications related to research 
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methodology.  For example, there were several factors related to HA-CDI hospitals 
upon performance of the risk-adjustment models.  These included the number of 2010 
HA-CDI cases, the proportion of patients greater than 65 years of age, the testing 
methodology utilized, and the hospital average length of stay.  Thus, it is important to 
calculate risk-adjusted cases of HA-CDI when comparing infection rates across 
hospitals.   
The organizational theory, institutional theory, provided a perspective to guide 
the development of study hypotheses.  That is, a framework was provided which 
allowed consideration of the isomorphic forces that shape an organization’s response to 
environmental pressures, such as the need to adopt infection prevention measures 
targeted at HA-CDI, and to better explain variations in HA-CDI rates across hospitals.    
Of the eight hypotheses, however, only one was supported.  There are several study 
limitations that may have contributed to this, such as variable measurement (see 
Limitations section below), but this may also be due to limitations of using an 
institutional theory perspective to evaluate factors associated with HA-CDI occurrence 
among hospitals.  For one, additional organizational theories, such as organizational 
behavior theories, may offer further explanatory power in regards to assessing hospital 
response to HA-CDI.  For example, what, if any, aspects of infection prevention 
teamwork contribute to HA-CDI occurrence.  Further, a macro-level theory does not 
inform on the unit-level of an individual organization, or even an individual patient-level.  
A more appropriate perspective may be one that accounts for different levels of an 
organization (Diez Roux & Aiello, 2005). 
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Limitations 
  A limitation to this research stems from the inherent problems of conducting 
research using administrative data (Schneeweiss & Avorn, 2005).  The ICD-9-CM 
codes, for example, are assigned by medical coders, who may not be able to correctly 
identify CDI as well as a physician or other medical professionals.  Further, depending 
upon POA coder accuracy, the type of case of CDI, whether HA-CDI or CO CDI, may 
have been misclassified.  The validation of antibiotic use and duration data acquired 
from the UHC CRM has been conducted, however (Schmiedeskamp, Harpe, Polk, 
Oinonen, & Pakyz, 2009).  It was found that all drugs identified by the database were 
actually administered to patients, except for non-formulary antibiotics that were 
administered, but not captured by the database.  Antibiotic use data were validated in 
only one UHC hospital, it is possible that this does not reflect all hospitals; however, it is 
not expected that the validation results would differ greatly across academic health 
centers.  Another limitation is that there are no data available regarding infection 
prevention efforts being conducted at hospitals, such as environmental cleaning and 
CDI patient isolation policies.  However, even if data were available on these polices, it 
would not be possible to ascertain the extent of adoption or effectiveness of the policies.  
Further, the UHC data does not provide information concerning antimicrobial 
stewardship program policies directed towards prevention of HA-CDI.  However, the 
main goal of antibiotic stewardship programs is to reduce inappropriate antibiotic use 
(Dellit et al., 2007); the incorporation of the amount of antibiotics used in hospitals is 
incorporated in the risk-adjustment model and should account for any antibiotic 
stewardship program initiatives.  One of the strengths of the UHC CRM data is the 
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availability of drug usage data; lack of these data was commonly a major weakness to 
other investigations concerning HA-CDI.   
Another limitation is that results of the current research are subject to the 
ecological fallacy, that is, the results may not necessarily reflect risk factors for HA-CDI 
at the unit-level; each hospital unit can have its own subculture (Lee et al., 2012).  
Further, the results of the study do not establish causal relationships between the 
factors studied and their impact on HA-CDI occurrence.  Not all academic health 
centers are UHC members, however nearly 90% are members, so while it is possible 
that a selection bias exists, it would not be expected to have a large impact on the 
results.   Another limitation is the inability to test for interactions among the variables 
given the relatively small sample size of hospitals.  Further, there exists potential 
endogenous variables in the models.  For example, when assessing the impact of 
mandatory public reporting of HA-CDIs, it is possible that states that implemented these 
policies had higher rates of HA-CDI than states that did not implement mandatory HA-
CDI reporting. Finally, the results of the study are only applicable to academic health 
centers, the results will not necessarily reflect on other types of hospitals.  
A final area of limitation is that the variables constructed to test the generated 
hypotheses are proxies for the intended measures.  For example, for the hypothesis 
testing the influence of mandatory reporting of CDI, the current study assessed CDI 
rates based on physician diagnoses for coding and reporting.  However, for state 
mandatory reporting, laboratory-identified CDI rates (LabID) are reported; these rates 
are based on positive laboratory tests and do not incorporate clinical evaluation.  A 
comparison between LabID events and CDI cases obtained from surveillance by 
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hospital infection preventionists among six hospitals in Rhode Island demonstrated that 
the LabID CDI events exceeded the surveillance rates (Baier, Morphis, Marsella, & 
Mermel, 2013).  Another study that compared LabID event reporting to clinical infection 
surveillance reporting among 30 hospitals in New York found that there was 81.3% 
agreement between the two methods, with the LabID CDI rates being higher across 
hospitals than the rates acquired by clinical infection surveillance reporting (Gase, 
Haley, Xiong, Van Antwerpen, & Stricof, 2013).  
Further, the Leapfrog Group composite safety score for hospitals reflects only a 
portion of measures that capture patient safety in hospitals.  Further, few outcome 
variables are represented in the composite score, and a number of measures are 
derived from administrative as opposed to clinical data (Austin et al., 2013).  The U.S. 
News & World Report Best Hospital Honor Roll ranking is also based on administrative 
and reputational data to a large degree.  
Regarding the variables measuring the rates of CLABSIs and CAUTIs in 
hospitals, the CLABSI and CAUTI SIR, reported on the Hospital Compare website, is 
dependent upon accurate data recording by hospitals. Some hospitals may have under-
reported these infections.  One report found that in Oregon, an external validation 
review of hospital-reported CLABSIs resulted in an increase in the statewide ICU 
CLABSI rate (Oh et al., 2012).  Another study conducted in Connecticut found that 
CLABSI surveillance performed by hospitals was only 48% sensitive (Backman, 
Melchreit, & Rodriguez, 2010).   Another limitation with the CLABSI SIR measure in 
particular, is that there may be hospital-acquired bloodstream infections that are 
misclassified as CLABSI, since the infection may be due to a secondary source, such 
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as translocation, rather than a catheter, resulting in the over-calling of CLABSIs 
(Digiorgio et al., 2012).  Thus, it is possible that the study results for this variable may 
be influenced by case misclassification, especially if there were varying degrees of 
sensitivity or specificity concerning HA-CDI case ascertainment among hospitals. 
Finally, the measure of Magnet status hospital, which was included as a metric 
for nursing quality, also has potential limitations as a proxy measure.  For example, one 
study that compared perceptions of hostility and job satisfaction among newly registered 
nurses from Magnet and non-Magnet hospitals found that nurses at both Magnet and 
non-Magnet-hospitals experienced nursing hostility and had similar job satisfaction 
scores (Hickson, 2013).  Thus, the Magnet-status designation of a hospital may not fully 
reflect aspects of an individual nurse’s workplace environment.  Further evaluations of 
nursing satisfaction in Magnet hospitals vs. non-magnet hospitals are needed to 
delineate the usefulness of the Magnet designation as a marker for nursing quality. 
Finally, for the measure of CDI physician experts, it is possible that there are healthcare 
professionals other than physicians serving as Physician Champions and that there are 
likely healthcare Professional Champions that did not serve as CDI guideline committee 
members.   
Suggestions for Future Study 
 In addition to the additional research needed in areas regarding Magnet 
designation, safety performance measures, and state policies on CDI as described 
above, there are several other research inquiry lines for future evaluation.  First, future 
studies should examine the factors related to decreased HA-CDI in Safety-net provider 
hospitals.  Though Safety-net hospitals are thought to be at a potential disadvantage in 
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having patient populations comprised of lower-income persons, the quality of care at 
Safety-net and non-Safety-net hospitals has been demonstrated to be nearly equal 
(Ross et al., 2012).  In the current study, the rate of HA-CDI was significantly lower in 
Safety-net hospitals as compared to non-Safety-net hospitals.  One factor that may be 
related to this is the amount of outpatient antibiotic use that is utilized by the 
surrounding hospital population.  It has been reported that higher population-level 
antibiotic prescription rates were associated with higher hospital CDI rates (Daneman et 
al., 2012).  It is possible that population antibiotic use may be lower in communities 
surrounding safety-net provider hospitals than in non-safety-net hospital communities.  
A follow-up evaluation into antibiotic prescribing patterns in the communities 
surrounding the study hospitals and the relationship to HA-CDI occurrence is warranted.  
 A second area of future study is the evaluation of the relationship between 
decreased market competition and lower HA-CDI found in the current study.  Though 
increased competition has been shown to be related to better outcomes in some quality 
areas, the opposite finding was found in the current study.  Similar to the discussion in 
the previous section regarding Safety-net  provider hospitals, it is possible that patients 
hospitalized in hospitals located in markets with decreased competition have less 
exposure to healthcare facilities, and are hospitalized in hospitals with a lower CO CDI 
prevalence.  In addition, it is possible that there is less outpatient antibiotic in 
communities that are in lower hospital-concentrated markets.   
 A third area of future study is the examination of the Best Hospital Honor Roll 
designation and the Leapfrog Group Patient Safety Score on other types of HAIs in 
addition to HA-CDI, such as CLABSIs, CAUTIs, and post-surgical infections.  Further, 
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more research is needed regarding the correlation of hospital performance ranking 
systems among hospitals. That is, if a hospital ranks well in the U.S. News & World 
Report Best hospitals ranking, does it also perform well in other scoring systems related 
to hospital quality. 
Conclusions 
 Using an institutional perspective, this study evaluated organizational factors 
related to HA-CDI, including the impact of state-led CDI Prevention Collaboratives, state 
mandatory HA-CDI reporting, Magnet status, the rate of CLABSIs and CAUTIs, CDI 
Physician Champions, and the performance ranking systems of the U.S. News & World 
Report and the Leapfrog Group.  Of the eight study hypotheses proposed, one was 
supported.  That is, hospitals with a higher Leapfrog Group Safety Score had HA-CDI 
rates that were no different than hospitals with lower Safety Scores.  Further, it was 
found that Best Hospital Honor Roll member hospitals had significantly higher rates of 
HA-CDI, though it was proposed that their rates would be no different than non-Honor 
Roll member hospitals.  The study results have potential implications concerning the 
role of regulatory policies aimed to decrease HA-CDI and the validity of quality 
performance ranking systems.           
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